Current Drug Shortages: Fospropofol disodium (Lusedra) injection
Tuesday, 19 June 2012 10:13
Acetylcysteine Inhalation Solution
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 100 mg/mL; 30 mL vial (NDC 0409-3307-03) | Next delivery June | Please check with your wholesaler for available inventory. | Manufacturing delay. | Revised 6/8/2012 |
| 200 mg/mL; 30 mL vial (NDC 0409-3308-03) | Next delivery July | ||||
| Roxane Laboratories 1-614-276-4000
| 200 mg/mL, 10 mL (NDC 00054-3028-02) | Roxane Laboratories has all acetylcysteine inhalation solution presentations on backorder and the company cannot provide an anticipate release date. | Manufacturing Delay | ||
| 200 mg/mL, 30 mL (NDC 00054-3026-02) | |||||
| American Regent/Luitpold 631-924-4000 | 100 mg/mL, 4 mL (NDC 00517-7504-25) | Unavailable | American Regent is currently not releasing Acetylcysteine inhalation solution. | Unavailable | Revised 6/8/2012 |
| 100 mg/mL, 10 mL (NDC 00517-7510-03) | |||||
| 200 mg/mL, 4 mL (NDC 00517-7604-25) | |||||
| 200 mg/mL, 10 mL (NDC 00517-7610-03) | |||||
| 200 mg/mL, 30 mL (NDC 00517-7630-03) |
Alfentanil Injection (Initial Posting Date) - 1/23/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Akorn Pharmaceuticals 1-800-932-5676 | 0.5 mg/ml; 2ml ampule (NDC 17478-0067-02) | 2 mL (NDC 17478-0067-02) is readily available. | Alfenta 2 mL and 5 mL ampoules are actively produced. | Increased demand | Revised 4/27/2012 |
| 0.5 mg/ml; 5ml ampule (NDC 17478-0067-05) | 5 mL (NDC 17478-0067-05) due for release May-end. | ||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 500 mcg/mL; 2 mL amp (NDC 0409-2266-02) | Next delivery June. | Please check your wholesaler for all available inventory. | Material shortage (API). | Revised 6/8/2012 |
| 500 mcg/mL; 5 mL amp (NDC 0409-2266-05) | Ample levels of inventory to meet market demand. |
| Company | Reason | Related Information | Date Updated |
|---|---|---|---|
| Teva Pharmaceuticals 1-800-545-8800 Amikacin 250 mg/mL 4 mL vials (NDC 00703-9040-03 | Available | Teva has released batches of amikacin 250 mg/mL 4 mL vials on 3/30/2012. The product is available for drop shipment and Teva is shipping to wholesalers on allocation. | Reverified 6/4/2012 |
| Bedford Customer Service 1-800-562-4797 250 mg/mL, 2 mL vials (NDC 55390-0226-02) | Manufacturing delays | Bedford Laboratories has 500mg/2ml and 1gm/4ml available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford Laboratories website. | Revised 4/10/2012 |
Amino Acid Products (Initial Posting Date) - 2/14/2012
For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition:
http://www.nutritioncare.org/Professional_Resources/Information_to_Use_in_the_Event_of_an_Intravenous_Amino_Acids_Shortage/
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | Aminosyn II 10%, Sulfite-free; 1 L bag (NDC 0409-4164-05) | Ample levels of inventory available to meet market demand | Please check with your wholesaler for available inventory.
Please see the Dear Customer Letter (PDF - 31KB) | Manufacturing delay; Higher than anticipated market demand. | Revised 6/11/2012 |
| Aminosyn 10%, Sulfite-free; 500 mL bag (NDC 0409-4191-03) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn 8.5%, Sulfite-free; 500 mL bag (NDC 0409-4187-03) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn II 10%; 2 L bag (NDC 0409-7121-07) | Product being replaced by (NDC 0409-7172-17) | ||||
| Aminosyn II 15%, Sulfite-free; 2 L bag (NDC 0409-7171-17) | Next delivery June. | ||||
| Aminosyn 10%, Sulfite-free, 1 L (NDC 0409-4191-05) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn II 10%, 500 mL, Sulfite-free (NDC 0409-4164-03) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn HBC 7%, 500 mL, Sulfite-free (NDC 0409-4168-03) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn 3.5%, sulfite-free, 1 L (NDC 0409-4196-05) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn 8.5%, sulfite-free, 500 mL (NDC 0409-4187-03) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn 10%, sulfite-free, 500 mL (NDC 0409-4191-03) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn II 8.5%, sulfite-free, 500 mL (NDC 0409-4162-03) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn II 8.5% with electrolytes, sulfite-free, 500 mL (NDC 0409-4171-03) | Next delivery June | ||||
| Aminosyn II 10%, sulfite-free, 1L (NDC 0409-4164-05) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn-PF 7%, sulfite-free, 500 mL (NDC 0409-4178-03) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn-PF 10%, 1000 mL, sulfite-free (NDC 0409-4179-05) | Ample levels of inventory available to meet market demand | ||||
| Aminosyn RF 5.2%, 500 mL, sulfite-free (NDC 0409-4166-03) | Ample levels of inventory available to meet market demand | ||||
| B. Braun Medical Inc. Customer Service: 1-800-227-2862 | TrophAmine 6%, 500 mL (NDC 00264-9361-55) | All B. Braun Amino Acids are available. | BBraun may start allocation if demand starts to exceed their increased production plans. | Available | Revised 6/15/2012 |
| TrophAmine 10%, 500 mL (NDC 00264-9361-55) | |||||
| FreAmine III 10%, 1000 mL (NDC 00264-9010-55) | |||||
| Specialty Amino Acid Solutions FreAmine HBC 6.9%, 750 mL (NDC 00264-9350-55) | |||||
| NephrAmine 5.4%, 250 mL (NDC 00264-1909-55) | |||||
| HepatAmine 8%, 500 mL (NDC 00264-9371-55) | |||||
Baxter Customer Service:
| Travasol 10%, 500 mL (NDC 00338-0644-03) | Travasol products available Premasol products available Hepatosol product available
Clinimix and Clinimix E products are available | Baxter is currently experiencing a backorder situation on all presentations of Prosol and Clinisol due to unforeseen demand. Clinimix is a viable source of Amino Acids for most patients requiring parenteral nutrition. | Increase in product demand due to market supply issues. | Reverified 4/30/2012 |
| Travasol 10%, 1000 mL (NDC 00338-0644-04) | |||||
| Travasol 10%, 2000 mL (NDC 00338-0644-06) | |||||
| Prosol 20%, 2000 mL, sulfite-free (NDC 00338-0499-06) | |||||
| Clinisol 15%, 500 mL, sulfite-free (NDC 00338-0502-03) | |||||
| Clinisol 15%, 2000 mL, sulfite-free (NDC 00338-0502-06) | |||||
| Premasol 6%, 500 mL, sulfite-free (NDC 00338-1131-03) | |||||
| Premasol 10%, 500 mL, sulfite-free (NDC 00338-1130-03) | |||||
| Premasol 10%, 1000 mL, sulfite-free (NDC 00338-1130-04) | |||||
| Premasol 10%, 2000 mL, sulfite-free (NDC 00338-1130-06) | |||||
| Hepatosol 8%, 500 mL (NDC 00338-0504-03) | |||||
| CLINIMIX sulfite-free (2.75%, 4.25%, 5.0% Amino Acid in Dextrose) Injections in 1000 mL and 2000 mL Containers | |||||
| CLINIMIX E sulfite-free (2.75%, 4.25%, 5.0% Amino Acid with Electrolytes in Dextrose with Calcium) Injections in 1000 mL and 2000 mL Containers |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Hospira, Inc. Customer Service: | 5 mEq/mL; 20 mL vial (NDC 0409-6043-01) | Company estimates a release date by June | Please check with your wholesaler for available inventory. | Other manufacturer shortages/market withdrawal | Reverified 6/8/2012 |
Ammonul (sodium phenylacetate and sodium benzoate) Injection 10%/10% (9/18/2008)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
Ucyclyd Pharma, Inc. 1-888-829-2593, or 1-800-900-6389 with a representative available 24 hours, seven days a week. | See information in Related Information section. | Limited supplies continue to be available. Please see attached Dear Healthcare Professional Letter (PDF - 25KB) for important safety information. | Revised 4/26/2012 |
Amphetamine Mixed Salts, ER Capsules (updated 10/31/2011)
| Company | Products | Availability Information | Related Information | Reason | Date Updated |
|---|---|---|---|---|---|
| Shire Customer Service: 1-800-828-2088 Adderall XR capsules | 5 mg - 100 count (NDC 54092-0381-01) | Product availability for all dosage strengths is adequate. | API supply issues and uneven product distribution patterns. | ||
| 10 mg - 100 count (NDC 54092-0383-01) | |||||
| 15 mg - 100 count (NDC 54092-0385-01) | |||||
| 20 mg - 100 count (NDC 54092-0387-01) | |||||
| 25 mg - 100 count (NDC 54092-0389-01) | |||||
| 30 mg - 100 count (NDC 54092-0391-01) | |||||
| Teva Customer Service (888)838-2872 | 5 mg - 100 count (NDC 00555-0790-02) | Teva continues to release product as it becomes available. | API supply issues | Reverified 6/4/2012 | |
| 5 mg - 100 count (NDC 00555-0790-02) | Teva continues to release product as it becomes available. | ||||
| 10 mg - 100 count (NDC 00555-0787-02) | Teva continues to release product as it becomes available. | ||||
| 15 mg - 100 count (NDC 00555-0791-02) | Teva continues to release product as it becomes available. | ||||
| 20 mg - 100 count (NDC 00555-0788-02) | Teva continues to release product as it becomes available. | ||||
| 25 mg - 100 count (NDC 00555-0792-02) | Teva continues to release product as it becomes available. | ||||
| 30 mg - 100 count (NDC 00555-0789-02) | Teva continues to release product as it becomes available. | ||||
| Global Customer Service: (215)558-4300 | 10 mg ,100 count (NDC 00115-1329-01) | All finished product strengths are currently available on an allocated basis. | Inadequate finished product supply to support current market demand | ||
| 15 mg, 100 count (NDC 00115-1330-01) | |||||
| 20 mg, 100 count (NDC 00115-1331-01) | |||||
| 25 mg, 100 count (NDC 00115-1332-01) | |||||
| 30 mg, 100 count (NDC 00115-1333-01) |
Amphetamine Mixed Salts Immediate-Release Tablets (updated 1/12/2012)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Sandoz Customer Service: 1-609-627-8500 | 5 mg tablets, 100 count (NDC 00185-0084-01) | Releasing product as it becomes available. | Increase in demand | Reverified 6/7/2012 | |
| 10 mg tablets, 100 count (NDC 00185-0111-01) | |||||
| 20 mg tablets, 100 count (NDC 00185-0401-01) | |||||
| 30 mg tablets, 100 count (NDC 00185-0404-01) | |||||
| CorePharma 1-800-850-2719 | 5 mg tablets, 100 count (NDC 64720-0130-10) | CorePharma is releasing product as it becomes available. | Increase in demand | ||
| 10 mg tablets, 100 count (NDC 64720-0132-10) | |||||
| 20 mg tablets, 100 count (NDC 64720-0135-10) | |||||
| 30 mg tablets, 100 count (NDC 64720-0136-10) | |||||
| Teva Customer Service: 1-888-838-2872 | 5 mg tablets, 100 count (NDC 00555-0971-02) | Teva continues to release product as it becomes available. | API supply issues | Reverified 6/4/2012 | |
| 7.5 mg tablets, 100 count (NDC 00555-0775-02) | Teva continues to release product as it becomes available. | ||||
| 10 mg tablets, 100 count (NDC 00555-0972-02) | Teva continues to release product as it becomes available. | ||||
| 12.5 mg tablets, 100 count (NDC 00555-0776-02) | Teva continues to release product as it becomes available. | ||||
| 15 mg tablets, 100 count (NDC 00555-0777-02) | Teva continues to release product as it becomes available. | ||||
| 20 mg tablets, 100 count (NDC 00555-0973-02)30 mg tablets, 100 count (NDC 00555-0974-02) | Teva continues to release product as it becomes available. | ||||
| Adderall, 5 mg tablets, 100 count (NDC 00555-0762-02) | Teva continues to release product as it becomes available. | ||||
| Adderall, 7.5 mg tablets, 100 count (NDC 00555-0763-02) | Teva continues to release product as it becomes available. | ||||
| Adderall, 10 mg tablets, 100 count (NDC 00555-0764-02) | Teva continues to release product as it becomes available. | ||||
| Adderall, 12.5 mg tablets, 100 count (NDC 00555-0765-02) | Teva continues to release product as it becomes available. | ||||
| Adderall, 15 mg tablets, 100 count (NDC 00555-0766-02) | Teva continues to release product as it becomes available. | ||||
| Adderall, 20 mg tablets, 100 count (NDC 00555-0767-02) | Teva continues to release product as it becomes available. | ||||
| Adderall, 30 mg tablets, 100 count (NDC 00555-0768-02) | Teva continues to release product as it becomes available. |
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Hospira Inc. 1-877-946-7747 50,000 units/mL, 2 mL ampule (NDC 61703-418-07) | Change in manufacturing sites. | Hospira anticipates next delivery in December, 2012. | Reverified 6/8/2012 |
Asparaginase Injection (Initial posting– 5/24/2012)
| Company | Products | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Lundbeck 1-847-282-1000 | Elspar 10,000 IU/vial (NDC 67386-411-51) | Anticipated to be available late June/early July | Manufacturing Delays | 5/24/2012 |
Atracurium besylate (updated 2/27/2012)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Bedford Customer Service: 1-800-562-4797 | 10 mg/mL, 5 mL vial, single dose vial (NDC 55390-0102-05) | Bedford Laboratories has 50mg Inj SDV 5ml and 100mg Inj MDV 10ml available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford Laboratories website. | Manufacturing delays | Revised 4/10/2012 | |
| 10 mL vial, multi-dose vial (NDC 55390-0103-10) | |||||
| 5 mL Novaplus vial, single dose vial (NDC 55390-0180-05) | |||||
| 10 mL Novaplus vial, multi-dose vial (NDC 55390-0179-10) | |||||
| Sagent Pharmaceticals 1-866-625-1618 | 10 mg/mL, 5 mL single dose vial, (NDC 25021-659-05) | On allocation | Products launched end of May, 2012. | Reverified 6/11/2012 | |
| 10 mg/mL, 10 mL multi-dose vial (NDC 25021-672-10) | Available in late June. |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Amphastar Pharmaceuticals Inc. Customer Service: 1-800-423-4136 | 0.1 mg/mL, 10 mL, Luer-Jet Prefilled Syringe (*New NDC# 76329-3339-1) | Available | N/A | Available | Revised 6/5/2012 |
| Hospira, Inc. Customer Service: 1-877-946-7747 | 0.1 mg/mL; 10 mL Ansyr syringe (NDC 0409-1630-10) | Ample levels of inventory to support market demand. | Please check with your wholesaler for available inventory. | Manufacturing delay | Revised 6/8/2012 |
| 0.05 mg/mL; 5 mL Ansyr syringe (NDC 0409-9630-05) | Next delivery 2012 | ||||
| 0.1 mg/mL; 5 mL Lifeshield syringe (NDC 0409-4910-34) | Next delivery September | ||||
| 0.1 mg/mL; 10 mL Lifeshield syringe (NDC 0409-4911-34) | Next delivery December | ||||
| American Regent/Luitpold 1-800-645-1706 | 0.4 mg/mL, 0.5 mL ampule, package of 25 (NDC 00517-0805-25) | Unavailable | Discontinued ampoules
American Regent is currently not releasing Atropine Sulfate Injection. | Revised 6/8/2012 | |
| 0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-0401-25) | Unavailable | ||||
| 1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-1010-25) | Unavailable | ||||
| 1 mg/mL, 1 mL ampule, package of 25 (NDC 00517-0101-25) | Unavailable | ||||
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 (Formerly a Baxter Product) | 0.4 mg/mL, 20 mL vial | Limited quantities. Additional lots will also be manufactured in July 2012 | Product will be made available as it is released. | Increase in product demand. | Revised 5/31/2012 |
Boniva (ibandronate sodium) Injection (Initial posting-6/6/2012)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Genentech, Inc. Customer Service: 1-800-551-2231 | 3 mg/mL (single use syringe) Box of 1 (NDC 0004-0191-09 | Next delivery 3rd week of June. | Please check with your wholesaler for available inventory. | Demand currently exceeding forecast |
Bupivacaine Hydrochloride Injection
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | APP has Sensorcaine (with & without Epinephrine) on intermittent back-order and the company is releasing product as it becomes available. Check Wholesaler Inventory. | Increased demand | Reverified 5/25/2012 | ||
Hospira, Inc.
| 0.25%; 30 mL amp (NDC 0409-1158-01) | Next delivery June | Please check with your wholesaler for available inventory. | Manufacturing delays | Revised 6/8/2012 |
| 0.25%; 10 mL vial (NDC 0409-1159-01) | Next delivery June | ||||
| 0.25%; 30 mL vial (NDC 0409-1159-02) | Next delivery June | ||||
| 0.25%; 50 mL vial (NDC 0409-1160-01) | Next delivery June | ||||
| 0.5%; 10 mL vial (NDC 0409-1162-01) | Next delivery June | ||||
| 0.5%; 30 mL vial (NDC 0409-1162-02) | Next delivery June | ||||
| 0.75%; 10 mL vial (NDC 0409-1165-01) | Next delivery July | ||||
| 0.75%; 30 mL vial (NDC 0409-1165-02) | Next delivery July | ||||
| 0.25% w/epi 1:200,000; 10 mL vial (NDC 0409-9042-01) | Next delivery July | ||||
| 0.25% w/epi 1:200,000; 30 mL vial (NDC 0409-9042-17) | Ample levels of inventory available to meet market demand. | ||||
| 0.25% w/epi 1:200,000; 50 mL (NDC 0409-9043-01) | Next delivery June | ||||
| 0.5% w/epi 1:200,000; 10 mL vial (NDC 0409-9045-01) | Next delivery July. | ||||
| 0.5% w/epi 1:200,000; 30 mL vial (NDC 0409-9045-17) | Ample levels available to meet market demand. | ||||
| 0.5% w/epi 1:200,000; 50 mL vial (NDC 0409-9046-01) | Next delivery June | ||||
| 50 mg/20 mL Sterile pack amp (NDC 0409-4272-01) | Next delivery June |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Bedford 1-800-562-4797 | 1 mL vial (NDC 55390-0010-10) | Bedford has buprenorphine injection on back order and the company cannot estimate a release date. | Delays | ||
| Hospira 1-877-946-7747 | 1 mL Carpuject syringe (NDC 00409-2012-32 | Hospira anticipates next delivery in September, 2012. | Product modification | Reverified 5/25/2012 | |
| American Regent/Luitpold 1-800-645-1706 | 1 mL vial (NDC 00517-0725-05) | Unavailable | Currently not releasing. | Revisedified 6/8/2012 | |
| Reckitt Benckiser 804-379-1090 Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) | Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) are available | Reckitt Benckiser has Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) available. |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Hospira, Inc. | 1 mg/mL; 1 mL vial (NDC 0409-1623-01) | Next delivery July | Please check with your wholesaler for all available inventory.
| Other manufacturer shortage/market withdrawal. | Reverified 6/8/2012 |
2 mg/mL; 1 mL vial (NDC 0409-1626-01) | Next delivery July | ||||
2 mg/mL; 2 mL vial (NDC 0409-1626-02) | Next delivery July | ||||
| Bedford Customer Service: 1-800-562-4797 | 1 mg/mL 1 mL vial (NDC 55390-0183-01) | Bedford has all butorphanol presentations on back order and the company cannot estimate a release date. | Manufacturing delays | ||
| 1 mg/mL 1 mL Novaplus vial (NDC 55390-0341-10) | |||||
| 2 mg/mL 1 mL vial (NDC 55390-0184-01) | |||||
| 2 mg/mL 2 mL vial (NDC 55390-0184-02) | |||||
| 2 mg/mL 1 mL Novaplus vial (NDC 55390-0342-10) | |||||
| 2 mg/mL 10 mL vial (NDC 55390-0185-10) |
Caffeine, anhydrous (125 mg/mL) and Sodium benzoate (125 mg/mL)
| Company | Product | Availability Information | Notes | Reason | Related Information |
|---|---|---|---|---|---|
| American Regent/Luitpold: 631-924-4000 | 2 mL single-dose vial, package of 10 (NDC 00517-2502-10) | Unavailable | Currently not releasing. | Revised 6/8/2012 |
Caffeine and Ergotamine Tartrate Tablet (Initial Posting-3/8/2012)
| Company/Products | Reason | Related Information | Related Information |
|---|---|---|---|
| Sandoz Customer Service: 1-609-627-8500 100 mg caffeine/ 1 mg ergotamine tartrate; 100 count bottle (NDC 00781-5405-01 | Change in the raw material plant location | Temporarily unavailable and Sandoz cannot estimate a release date. We will continue to provide updates as further information becomes available | Reverified 6/7/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| American Regent/Luitpold 1-800-645-1706 | 1 mcg/mL; 1 mL ampule, 25 count (NDC 00517-0132-25) | Available | Please check with your wholesaler for available inventory. | Revised 6/8/2012 | |
| APP Pharmaceuticals 1-888-386-1300 | 1 mcg/ml; 1 mL ampule, 50 count (NDC 63323-0731-01 | Available | Please check wholesalers for inventory. | Available | Reverified 5/25/2012 |
| Akorn Pharmaceuticals 1-800-932-5676 | Akorn 1 mL ampule, 10-pack (NDC 17478-0931-01) | This product is immediately available. | n/a | Revised 4/27/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Hospira Inc. | 100 mg/mL; 10 mL Abboject
(NDC 0409-4928-34) | Next delivery June | Please check with your wholesaler for available inventory. | Manufacturing delay | Revised 6/8/2012 |
100 mg/mL; 10 mL Ansyr (NDC 0409-1631-10) | Ample levels available to meet market demand. | ||||
| American Regent/Luitpold 1-800-645-1706 | 10%, 10 mL vial NDC 0517-2710-25 | Available |
| Please check with your wholesaler for available inventory. | Revised 6/8/2012 |
Amphastar Pharmaceuticals, Inc. Customer Service
| Calcium Chloride Inj. USP, 10%, 10mL Luer-Jet Prefilled Syringe (NDC 0548-3304-00) (*New NDC# 76329-3304-1) | Available | N/A | Available | Revised 6/5/2012 |
Cardiolite, Kit for the Preparation of Technetium Tc99m Sestamibi for Injection (Initial Posting Date) – 5/4/2012
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Lantheus Medical Imaging 1-800-299-3431 CARDIOLITE, Kit for the Preparation of Technetium Tc99m Sestamibi for Injection Supplied in 5 vial kit (NDC #11994-001-55) and 20 vial kit (NDA # 11994-001-20) | Manufacturing delays at contract manufacturer and limited supply available from alternate contract manufacturer. | Lantheus has limited supplies available and continues to release product as it becomes available. |
Chloroprocaine (Nesacaine) Injection (Initial Posting 3/28/2012)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 10 mg/mL with preservative, 30 mL vial, 25 count (NDC 63323-0475-37) | Estimated release date of late May 2012. | All strengths on backorder with an estimated release date of late May 2012. | Increased Demand | 5/29/2012 |
| 20 mg/mL with preservative, 30 mL vial, 25 count (NDC 63323-0476-37) | |||||
| 30 mg/mL preservative-free, 20 mL vials, 25 count (NDC 63323-0478-27) | |||||
| Bedford Laboratories | 20 mg/mL preservative-free, 20 mL vials (NDC 55390-0403-20) | Bedford Laboratories is out of stock and the company cannot estimate a release date. | Production is pending as capacity permits. Availability of products is updated on the Bedford Laboratories website . | Manufacturing delays | 3/28/2012 |
| 30 mg/mL preservative-free, 20 mL vials (NDC 55390-0404-20) |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service 1-877-946-7747 | 4 mcg/mL; 10 mL vial (NDC 0409-4093-01) | Next delivery October |
| Other manufacturer shortage/market withdrawal. | Reverified 6/8/2012 |
| American Regent/Luitpold 1-800-645-1706 | SOL 4 mcg/ml INTRAVENOUS 10 ml 25s (NDC 00517-6310-25) | Unavailable | Currently not releasing | Revised 6/8/2012 |
Cisplatin injection 1 mg/mL solution
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300
| 1 mg/ml; 50 mL vial (NDC 63323-0103-51) | All available | Please check wholesalers for inventory. | Revised 5/29/2012 | |
| 1 mg/ml; 100 mL vial (NDC 63323-0103-65) | |||||
| 1 mg/ml; 200 mL vial (NDC 63323-0103-64) | |||||
Teva Pharmaceuticals
| 1mg/mL, 50 mg (NDC 00703-5747-11) | Ample inventory of both presentations | Increased Demand | Reverified 6/4/2012 | |
| 1mg/mL, 100 mg (NDC 00703-5748-11) | |||||
| Bedford 1-800-562-4797 | All presentations discontinued | Product discontinued |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Ferring Pharmaceuticals, Inc. 1-888-Ferring (1-888-337-7464) | EQ 0.1 MG Base/Vial (NDC 55566-0302-1) | No stock available | Manufacturing delay | Reverified 6/15/2012 |
Daunorubicin Hydrochloride Solution for Injection
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Teva Pharmaceuticals 1-800-545-8800 5 mg/mL, 4 mL single-dose vial (NDC 00703-5233-13) | Increased Demand | Teva has daunorubicin available but the company is reviewing orders prior to release. | Reverified 6/4/2012 |
Bedford Customer Service 5 mg/mL, 4 mL single-dose vial (NDC 55390-0108-10)
10 mL single-dose vial (NDC 55390-0108-01)
Cerubidine lyophilized powder for injection, 20 mg single-dose vial, package of 10 (NDC 55390-0281-10) | Manufacturing delays | Bedford Laboratories has 5 mg/mL in 4 mL and 10 mL single-dose vials and 20 mg cerubidine lyophilized powder for injection available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford Laboratories website | Revised 4/10/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Ferring
| 4 mcg/mL 1ml vials (NDC 55566-5030-01) | Available | Available | Revised 6/15/2012 | |
| 4mcg/mL 10ml (NDC 55566-5040-01) | Available | ||||
| Hospira Inc. Customer Service: 1-877-946-7747 | 4 mcg/mL, 1 mL amp (NDC 00409-2265-01) | Next delivery June | Please check with your wholesaler for available inventory.
| Manufacturing delay | Reverified 6/8/2012 |
| Sanofi-Aventis 1-800-981-2491
| (DDAVP) 4 mcg/mL; 1 mL ampule (NDC 00075-2451-01) | Both presentations available. | Available | Reverified 6/15/2012 | |
| 4 mcg/mL; 10 mL vial (NDC 00075-2451-53) | |||||
Teva Pharmaceuticals
| 4mcg/mL, 4mcg (NDC 00703-5051-03) | All presentation on back order and the company cannot estimate a release date. | Manufacturing delays | Reverified 6/4/2012 | |
| 4mcg/mL, 40 mcg (NDC 00703-5054-01) |
Desmopressin Intranasal (Initial posting) – 5/9/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Sanofi-Aventis 1-800-981-2491 | Rhinal Tube: 0.1 mg/mL; 2.5 mL Bottle (NDC 00075-2450-01) | Resumption of shipment to wholesalers beginning on 6/18/12. | Revised 6/15/2012 | ||
| Nasal Spray: 0.1 mg/mL 5 mL Bottle (NDC 00075-2452-01 | Available |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Mylan Institutional 1-888-258-4199 | 250 mg vial (NDC 67457-0207-25) | Mylan Institutional has made product available. | Please check with the wholesaler for availability. | Increased demand | Revised 5/30/2012 |
| 500 mg vial (NDC 67457-208-50) | |||||
| Pfizer Injectables 1-800-533-4535 | Pfizer has product available for both strengths. | Pfizer Injectables has available vials of 250 mg NDC (0013-8717-62), 500 mg (NDC 0013-8727-89). | Reverified 5/21/2012 | ||
| Topotarget USA, Inc. 1-973-895-6900 | Totect 500 mg (dexrazoxane) for injection (NDC 38423-110-01) | Topotarget USA has worked with the US Food and Drug Administration (FDA) to increase the availability of Totect Kits. Effective February 6, 2012, the FDA has approved the extension of the expiration date to 36 months for Totect Kits with following batch numbers: Topotarget USA, Inc. has recently released additional 129 kits to help fill the back order for this product. The company cannot estimate a release for additional Totect Kits at this time. | Manufacturing Delays | Revised 4/26/2012 |
Dextroamphetamine Tablets (1/12/2012)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Teva Pharmaceuticals 1-800-545-8800 | 5 mg tablets, 100 count (NDC 00555-0952-02) | Product will be released as it becomes available. | Teva has dextroamphetamine 5 mg and 10 mg, 100 count tablets but will be on intermittent back order through mid-2012. | Manufacturing delays | Reverified 6/4/2012 |
| 10 mg tablets, 100 count (NDC 00555-0953-02) | Product will be released as it becomes available. |
Dextrose Injection (Initial posting – 5/23/2012)
| Company | Products | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. Customer Service: 1-800-423-4136 | Dextrose Inj. USP, 50%, 50 mL Luer-Jet Prefilled Syringe (NDC 0548-3301-00) (*New NDC# 76329-3301-1) | Amphastar will regularly release products as it comes available. | Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues. | Increased Demand | Revised 6/5/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 5 mg/mL; 2 mL Carpuject (0409-1273-32) | Next delivery August | Manufacturing delay | Revised 6/8/2012 | |
| 5 mg/mL; 10 mL vial (0409-3213-12) | Next delivery June |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| West-Ward Pharmaceuticals Customer Service: 1-888-229-0001 (Formerly a Baxter Product) | 250 mcg/mL, 2 mL ampuls (NDC 0641-1410-35) | Available. Production has been accelerated and additional lots are scheduled to be released in August 2012. | Product will be made available as it is released. | Increase in product demand | Revised 5/31/2012 |
Covis Pharma S.à.r.l Customer Service: | Lanoxin Injection, USP 250 mcg/mL, 2 mL (10s - NDC 00173-0260-10) | Available | No longer on limited supply. | Available | Revised 6/13/2012 |
| Lanoxin Injection, USP 250 mcg/mL, 2 mL (50s - NDC 00173-0260-35) | Covis Pharma S.à.r.l has discontinued manufacturing Lanoxin Injection, USP 250 mcg/mL, 2 mL (50s - NDC 00173-0260-35). |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
West-Ward Pharmaceuticals Customer Service (Formerly a Baxter Product) | 5 mL vial | Multiple lots of each code are scheduled for production and units are expected to be available by the end of May – beginning of June 2012.
Additional lots of each code are scheduled for manufacturing and projected to be release in July – August 2012 timeframe. | West-Ward is currently experiencing a backorder situation on the 5 mL, 10 mL and 25 mL vials.
Product will be made available as it is released | Increase in product demand due to market supply issues | Revised 5/31/2012 |
10 mL vial (NDC 0641-6014-10) | |||||
25 mL vial (NDC 0641-6015-10) | |||||
| Hospira Customer Service (1-877-946-7747)
| 5 mg/mL, 5 mL vials (NDC 00409-1171-01) | Next delivery June | Please check with your wholesaler for available inventory.
| Other Manufacturer Shortages/Market Withdrawal | Reverified 6/8/2012 |
5 mg/mL, 10 mL vials (NDC 00409-1171-02) | Next delivery June | ||||
| 100 mg/mL, ADD-Vantage vials (NDC 00409-4350-03) | Ample supply available | ||||
| Bedford Customer Service 1-800-562-4797 | 5 mg/mL 5 mL vials (NDC 55390-0565-05), 5 mg/mL 10 mL vials (NDC 55390-0565-10) | Bedford Laboratories has 50mg Inj 10ml available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. The 25mg Inj 5ml vials are out of stock and the 125mg Inj 25ml vial is pending release with release date yet to be determined. Availability of products is updated on the Bedford Laboratories website. | Manufacturing delays | Revised 4/10/2012 | |
| 5 mg/mL 25 mL vials (NDC 55390-0565-30), 5 mg/mL 5 mL Novaplus vials (NDC 55390-0566-05) | |||||
| 5 mg/mL 10 mL Novaplus vials (NDC 55390-0566-10) | |||||
| 5 mg/mL 25 mL Novaplus vials (NDC 55390-0566-30) | |||||
| Akorn Pharmaceuticals 1-800-932-5676 | 5 mg/mL, 25 mL vials (NDC 17478-0937-25) | All SKUs ( 5 mL, 10 mL and 25 mL) are immediately available. |
| N/A | Revised 4/27/2012 |
Diphenhydramine Hydrochloride Injection
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 50 mg/ml, 1 ml (NDC 63323-0664-01) | Intermittent back-order | Please check wholesalers for inventory. | Increased in demand | Revised 5/29/2012 |
| Hospira Customer Service 1-877-946-7747 | 50 mg/mL; 1 mL Carpuject (NDC 0409-2290-31) | Next delivery June |
| Manufacturing delays | Reverified 6/8/2012 |
| Mylan Institutional 1-888-258-4199 | 50 mg/ml, 10 ml, 10s (NDC 67457-0124-10) | Expected release in Mid July 2012 | Increased demand | Revised 5/30/2012 | |
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 (Formerly a Baxter Product) | 50 mg/mL, 1 mL vial (NDC 0641-0376-25) | Available
Additional units will also be available in the June – July 2012 timeframe. | Product will be made available as it is released. | Increased in product demand. | Revised 5/31/2012 |
Doxorubicin (adriamycin) lyophilized powder (updated 12/2/2011)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Bedford 10 mg vials (NDC 55390-0231-01) 20 mg vials (NDC 55390-0232-10) 50 mg vial (NDC 55390-0233-01) | Manufacturing delays | Bedford Laboratories has 10 mg available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Other presentations are pending release with release date yet to be determined. Availability of products is updated on the Bedford Laboratories website. | Revised 4/10/2012 |
Doxorubicin Liposomal (Doxil) Injection
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Janssen Products, LP (formerly Centocor Ortho Biotech Products, L.P.) 1-800-526-7736 (1-800-JANSSEN) Doxil 2 mg/mL, Janssen Products, LP | Manufacturing delays | Please see http://www.doxil.com/sites/default/files/DHCP_september2011.pdf | |
| Sun Pharma Global FZE (Caraco Pharmaceutical, U.S. distributor) 1-888-835-2237 | Sun Pharma Global FZE, and its authorized distributor, Caraco Pharmaceutical Laboratories Ltd, in conjunction with the FDA, are initiating a temporary importation of Lipodox (doxorubicin HCL liposomal for injection), into the United States market to address this shortage. Please see the Dear Healthcare Professional Letter (PDF - 65KB) for information about supplies that are now available to help address the current shortage.
| 3/8/2012 |
Doxorubicin Solution for Injection
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 APP Product Availability Information | APP has available the 2 mg/mL 5 mL vials (NDC 63323-883-05), the 2 mg/mL 10 mL vials (NDC 63323-883-10), the 2 mg/mL 25 mL vials (NDC 63323-0883-30), and the 2 mg/mL 100 mL vials (NDC 63323-0101-61). | Increased demand | Reverified 5/25/2012 | ||
Teva Pharmaceuticals | 2 mg/mL; 5 mL vial (NDC 00703-5043-03) | Teva has available all presentation of Doxorubicin. | Teva is reviewing all orders before release. | Manufacturing delays | Revised 6/4/2012 |
| 2 mg/mL; 25 mL vial (NDC 00703-5046-01) | |||||
| 2 mg/mL; 100 mL vial (NDC 00703-5040-01) | |||||
| Bedford 1-800-562-4797 | Manufacturing delays | Bedford has all doxorubicin solution presentations on backorder and the company cannot estimate a release date. | |||
| Pfizer Injectables 1-800-533-4535 http://www.pfizerinjectables.com/ | Pfizer has product available | Pfizer Injectables has available vials of 10mg/5mL (NDC 0069-3030-20), 20mg/10mL (NDC 0069-3031-20), 50mg/25mL (NDC 0069-3032-20), 150mg/75mL (NDC 0069-3033-20), 200mg/100mL (NDC 0069-3034-20). | Reverified 5/21/2012 |
Epinephrine Injection (Initial Posting Date) – 4/27/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1:10,000; 10 mL Abboject-1 ½ “ needle(NDC 0409-4921-34) | Next delivery June | Please check with your wholesaler for available inventory. | Manufacturing delays | Revised 6/8/2012 |
| 1:10,000; 10 mL Abboject-3 ½ “ needle (NDC 0409-4901-18) | Next delivery June | ||||
| Amphastar Pharmaceuticals, Inc./IMS Customer Service: 1-800-423-4136 | Epinephrine Inj. USP, 1:10,000, 10mL, Luer-Jet Prefilled Syringe (NDC 0548-3316-00) (*New NDC# 76329-3316-1) | Amphastar will regularly release products. | Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues. | Increased Demand | Revised 6/5/2012 |
Erythromycin Lactobionate Injection (Initial posting-6/12/12)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 500 mg/vial; (NDC 0409-6482-01) | Next delivery September | Please check with your wholesaler for available inventory. | Higher than anticipated market demand |
Esomeprazole (Nexium) For Delayed-Release Oral Suspension (Initial Posting Date) - 4/10/2012
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| AstraZeneca 1-800-236-9933 10 mg packets, unit: dose packages of 30 (NDC 0186-4010-01) 20 mg packets, unit: dose packages of 30 (NDC 0186-4020-01) 40 mg packets, unit: dose packages of 30 (NDC 0186-4040-01) | Manufacturing delays | NEXIUM (esomeprazole) For Delayed-Release Oral Suspension, 10 mg, is no longer Out of Stock. Product will be on order management in May and June. NEXIUM (esomeprazole) For Delayed-Release Oral Suspension, 20 mg and 40 mg, will have limited availability during May and June. Order management will be implemented. | Revised 5/17/2012 |
Ethiodol (ETHIODIZED OIL) ampules
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Guerbet LLC Customer Service (1-877-729-6679) | Product has been discontinued by Nycomed US Inc. | Guerbet has acquired the Ethiodol NDA from Nycomed US Inc. effective May 7, 2010 and is working with FDA to resume manufacturing of Ethiodol in the near future to ensure continued availability for the US patients. During this interim period, Guerbet, in conjunction with the FDA, is initiating a temporary importation of LIPIODOL ULTRA-FLUIDE, ethyl esters of iodized fatty acids of poppy seed oil, to the United States market. See Dear Healthcare Professional Letter (PDF - 483KB) for additional information. | Revised 3/16/2012 |
Etomidate Injection (Initial Posting Date) - 2/9/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| American Regent/Luitpold 1-800-645-1706 | 2 mg/mL vial 10 mL vial (NDC 00517-0780-10) | Unavailable
| Currently not releasing. | Revised 6/8/2012 | |
| 20 mL vial (NDC 00517-0781-10) | |||||
| Hospira Inc. Customer Service 1-877-946-7747 | 2 mg/mL; 10 mL vial (NDC 0409-6695-01) | Next delivery July | Please check with your wholesaler for available inventory. | Manufacturing Delay | Revised 6/8/2012 |
| 2 mg/mL; 20 mL vial (NDC 0409-6695-02) | Next delivery September | ||||
| 2 mg/mL; 20 mL Abboject syringe (NDC 0409-8060-29) | Next delivery September | ||||
| 2 mg/mL; 20 mL amp (NDC 0409-8061-01) | Next delivery September | ||||
| 2 mg/mL; 10 mL amp (NDC 0409-8062-01) | Next delivery September | ||||
| Bedford Customer Service: 1-800-562-4797 | 2 mg/mL injection 10 mL vial (NDC 55390-0762-10) | Etomidate injection is on back order with no estimated date of availability. | Manufacturing Delay | ||
| 20 mL (NDC 55390-0763-20) | |||||
| Pfizer Customer Service: Pfizer Injectables 1-800-533-4535 | 20 mg/10ml injection (NDC 0069-0006-01) | Pfizer has limited supply of etomidate injection, 20 mg/10ml injection (NDC 0069-0006-01) and 40mg/20ml injection (NDC 0069-0006-03). |
| Available | Reverified 5/21/2012 |
| 40 mg/20ml injection (NDC 0069-0006-03) |
Etoposide solution for injection
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Bedford
| 100 mg/5 mL (NDC 55390-0291-01) | Available in limited quantities | Once this supply is depleted, the next estimated release dates are unknown. The company cannot estimate a release date. Production is pending as capacity permits. Availability of products is updated on the Bedford Laboratories website. | Increased demand | Revised 4/10/2012 |
| 500 mg/25 mL (NDC 55390-0292-01) | Out of stock | ||||
| 1g/50 mL (NDC 55390-0293-01) | Out of stock | ||||
Teva Pharmaceuticals
| Toposar 20 mg/ml; 5 mL vial (NDC 00703-5653-01) | All solutions are available. | Reverified 6/4/2012 | ||
Toposar 20 mg/ml; 25 mL vial (NDC 00703-5656-01) | |||||
Toposar 20 mg/ml; 50 mL vial (NDC 00703-5657-01) | |||||
APP
| 20 mg/mL; 5 mL vial (NDC 63323-0104-05) | Available | APP has all presentations of Etoposide available. Check wholesalers for inventory. | Revised 5/29/2012 | |
| 20 mg/ml; 25 mL vial (NDC 63323-0104-25) | |||||
| 20 mg/ml;50 mL vial (NDC 63323-0104-50) | |||||
| BMS Customer Service 1-800-426-7644 | BMS has available Etopophos 100 mg powder for injection (NDC 00015-3404-20). | Increased demand | |||
| Accord Healthcare Customer Service: 919-941-7879 | 20mg/mL, 5mL vial (NDC# 16729-114-31) | Available at this time. | Orders are being shipped out. | Revised 6/14/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 0.05 mg/mL; 2 mL Carpuject (0409-1276-32) | Next delivery August | Carpuject orders (NDC 0409-1276-32) may be placed direct or through the wholesaler, and will be filled in the order in which received.
Fentanyl products listed above must be ordered through the wholesaler; check with your wholesaler regarding product allocation. It is recommended that the user institute fentanyl sparing strategies. | Manufacturing delay | Revised 6/8/2012 |
| 0.05 mg/mL; 2 mL amp (0409-9093-32) | Next anticipated delivery August | ||||
| 0.05 mg/mL; 5 mL amp (0409-9093-35) | Next anticipated delivery June | ||||
| 0.05 mg/mL; 20 mL amp (0409-9093-38) | Next anticipated delivery September | ||||
| 0.05 mg/mL; 2 mL vial (0409-9094-22) | Next anticipated delivery June | ||||
| 0.05 mg/mL; 5 mL vial (0409-9094-25) | Next anticipated delivery June | ||||
| 0.05 mg/mL; 10 mL vial (0409-9094-28) | Next anticipated delivery June | ||||
| 0.05 mg/mL; 20 mL vial (0409-9094-31) | Next anticipated delivery June | ||||
| 0.05 mg/mL; 50 mL vial (0409-9094-61) | Next anticipated delivery June | ||||
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 (Formerly a Baxter Product) | 50 mcg/mL 2 mL ampul | Multiple lots of the 2 mL, 5 mL, and 20 mL ampuls are anticipated to be released and available in the June - July 2012 timeframe. | West-Ward is currently experiencing a backorder situation on all presentations due to market demand. Product will be made available as it is released.
| Increase in product demand due to market supply issues. | Revised 6/6/2012 |
| 5 mL ampul (NDC 10019-033-72) | |||||
| 20 mL ampul (NDC 10019-035-74) | Scheduled to be manufactured and available for release in the June – July 2012 timeframe. Several additional lots of the vial codes are projected to be manufactured in August 2012. | ||||
| 2 mL vial (NDC 10019-037-27) | |||||
| 5 mL vial (NDC 10019-037-30) | |||||
| 20 mL vial (NDC 10019-037-25) | |||||
| 50 mL vial (NDC 10019-037-83) | |||||
| Akorn Pharmaceuticals 1-800-932-5676 | 2 mL (NDC 1748-0030-02) | 2 mL is released and available to wholesalers and direct customer via controlled allocation. | Increased production available, contingent on market demand. | N/A | Revised 4/27/2012 |
| 5 mL (NDC 1748-0030-05) | 5 mL is immediately available. | ||||
| 20 mL (NDC 1748-0030-20) | 20 mL released and available to wholesalers and direct customer via controlled allocation. |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Mylan Institutional 1-888-258-4199 | 50 mg/mL,10 mL vial (NDC 10139-0063-11) | Presentations, 10, 20 and 50 mL are in stock and available. | Mylan Institutional (formerly Bioniche Pharma) has Fluorouracil Injection 50 mg/mL, 100 mL vials available for drop shipment orders through wholesalers at this time.
| Increased demand | Reverified 5/30/2012 |
| 50 mg/mL,20 mL vial (NDC 10139-0063-12) | |||||
| 50 mg/mL,50 mL vial (NDC 10139-0063-50) | |||||
| 50 mg/mL, 100 mL vial (NDC 10139-0063-01 | 100 mL vials available for drop shipment orders through wholesalers at this time. | ||||
Teva Pharmaceuticals | 50 mg/mL, 10 mL vial (NDC 00703-3015-13) | Ample inventory of the 50 mg/mL in 10ml vials. | Increased Demand | Revised 6/4/2012 | |
| 50 mg/mL, 50 mL vial (NDC 00703-3018-12) | Ample inventory of the 50 mg/mL in 50mL vials. | ||||
| 50 mg/mL, 100 mL vial (NDC 00703-3019-12) | Teva will have limited inventory of the 50 mg/mL in 100 mL presentation through June. | ||||
APP
| 50 mg/ml; 10 mL vial (NDC 63323-0117-10) | Available | APP has all presentations of Fluorouracil available. Check with wholesalers for inventory. | Revised 5/29/2012 | |
| 50 mg/ml; 20 mL vial (NDC 63323-0117-20) | |||||
| 50 mg/mL; 50 mL vial (NDC 63323-0117-51) | |||||
| 50 mg/mL; 100 mL vial (NDC 63323-0117-61) |
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Hospira, Inc. Customer Service 1-877-946-7747 24 mg/mL; 250 mL bottle 24 mg/mL; 500 mL bottle | Production temporarily suspended | Hospira has partnered with Clinigen to distribute UK product. See Clinigen posting below with Dear Healthcare Professional Letter for details. | Reverified 6/8/2012 |
| Clinigen Healthcare | Please see attached Dear Healthcare Professional Letter (PDF - 519KB) for updated information regarding distribution. |
Fosphenytoin Sodium Injection (Initial posting 3/30/12)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service 1-877-946-7747 | 75 mg/mL; 2 mL vial (NDC 0409-4857-02) | Production of both presentations is temporarily suspended. | Temporary suspension | Reverified 6/8/2012 | |
| 75 mg/mL; 50 mL vial (NDC 0409-4857-10 | |||||
| APP Customer Service 1-888-386-1300 | NDC # 63323-403-02 (100 mg PE/2 mL, 2 mL vial) | Next releases expected early June. | All presentations currently back-ordered. Check wholesalers for available inventory. | Increase in Demand | Revised 5/29/2012 |
| NDC # 63323-403-10 (500 mg PE/10 mL, 10 mL vial) | |||||
West-Ward Pharmaceuticals
50 mg PE/mL | 2 mL vial (NDC 0143-9788-25) | Both presentations on backorder. At this time, West-Ward does not have a projected availability date. | Manufacturing delays | Revised 5/9/2012 | |
| 10 mL vial (NDC 0143-9782-10) |
Fospropofol disodium (Lusedra) Injection 
(Initial posting-6/18/12)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Eisai Inc Customer Service number- 1-888-422-4743 | 1050 mg/30 mL (35 mg/mL), 30 mL vial (NDC 62856-350-08) | Product is available until the end of July 2012. | Please check with your wholesaler for available inventory. | Suspension of manufacturing |
Ganite (gallium nitrate injection) (Initial Posting - 4/4/2012)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Genta Incorporated 1-888-TO-GENTA) | Business decision | No estimated date of availability. | 4/4/2012 |
Helidac (bismuth subsalicylate/tetracycline hydrochloride/metronidazole) Therapy (Initial Posting - 3/8/2012)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Prometheus Laboratories Inc. 1-888-423-5227 option 3 HELIDAC (bismuth subsalicylate/tetracycline hydrochloride/metronidazole) Therapy (NDC 65483-495-14) | Material Shortage (Tetracycline HCl capsules) | Prometheus has limited product available and cannot estimate a release date for new batches. |
Hydromorphone Hydrochloride Injection (Initial Posting-3/7/12)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1 mg/mL; 1 mL amp (NDC 0409-2552-01) | Next delivery June | Please check with your wholesaler for available inventory. | Material Shortage | Revised 6/8/2012 |
| 1 mg/mL; 1 mL iSecure (NDC 0409-1283-10) | Next delivery June | ||||
| 1 mg/mL; 1 mL Carpuject (NDC 0409-1283-31) | Next delivery June | ||||
| 2 mg/mL; 1 mL vial (NDC 0409-3365-01) | Next delivery June | ||||
| Product 2 mg/mL; 1 mL amp (NDC 0409-3356-01) | Next delivery June | ||||
| 4mg/mL; 1mL Carpuject (NDC 0409-1304-31) | Ample levels of inventory available to meet market demand. | ||||
| 2 mg/mL; 1 mL iSecure (NDC 0409-1312-10) | Next delivery September | ||||
| 2mg/mL; 1mL Carpuject (NDC 0409-1312-30) | Next delivery June | ||||
| 10mg/mL; 1mL Vial (NDC 0409-2634-01) | Next delivery June | ||||
| 10 mg/mL; 5 mL vial (NDC 0409-2634-05) | Ample levels of inventory available to meet market demand. | ||||
| 10 mg/mL; 50 mL vial (NDC 0409-2634-50) | Next delivery June | ||||
| Teva Pharmaceuticals 1-800-545-8800 | 10 mg/mL, 1 mL vials (NDC 00703-0110-03) | Teva has all presentations available. | Increased Demand | Reverified 6/4/2012 | |
| 10 mg/mL, 5 mL vials (NDC 00703-0113-03) | |||||
| 10 mg/mL, 50 mL vials (NDC 00703-0118-01) | |||||
| West-Ward Pharmaceuticals Customer Service: 1-888-229-0001 | 1 mL vial, 2 mg/mL (NDC 0641-0121-25) | West-Ward has increased production and is anticipating having multiple lots of both presentations available by the middle of June 2012.
Additional lots are schedule for production in the June – July 2012 timeframe. | West-Ward is currently experiencing a backorder situation on both the 1 mL and 20 mL vial presentations.
Product will be made available as it is released | Increase in product demand. | Revised 5/31/2012 |
| 20 mL vial, 2 mg/mL (NDC 0641-2341-41) | |||||
Akorn Pharmaceuticals
| 10 mg/mL, 1 mL ampules (NDC 17478-0540-01) | Readily available | Information pending | Revised 4/27/2012 | |
| 10 mg/mL, 5 mL ampules (NDC 17478-0540-05) | Releasing mid-April | ||||
| 10 mg/mL, 50 mL vials (NDC 17478-0540-50) | Readily available | ||||
| Purdue | 1 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0441-10) | Currently on backorder. Estimated release date is August 2012. | Manufacturing shortage | Revised 6/14/2012 | |
| 2 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0442-10) | Available | ||||
| 2 mg/mL, 1 mL ampules, package of 25 (NDC 59011-0442-25) | Currently on backorder. Estimated release date is July, 2012 | ||||
| 4 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0444-10) | Available | ||||
| Dilaudid-HP injection 250 mg vial, powder for injection (NDC 59011-0446-25) | Available | ||||
Dilaudid-HP injection 10 mg/mL, 1 mL ampules (NDC 59011-0445-01) | Available | ||||
Dilaudid-HP injection 10 mg/mL, 5 mL ampules (NDC 59011-0445-05) | Available | ||||
| Dilaudid-HP injection 10 mg/mL, 50 mL vials (NDC 59011-0445-50 | Available |
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 Liposyn III (fatemulsion/soybean oil) 10%; 250 mL (NDC 0409-9790-02) 10%; 500 mL (NDC 0409-9790-03) 20%; 250 mL (NDC 0409-9791-02) 20%; 500 mL (NDC 0409-9791-03) 30%; 500 mL (NDC 0409-6892-03) | Manufacturing delay | Products 10%; 250 mL (NDC 0409-9790-02), 10%; 500 mL (NDC 0409-9790-03), 20%; 250 mL (NDC 00409-9791-02), 20%; 500 mL (NDC 00409-9791-03) and 30%; 500 mL (NDC 00409-6892-03): Hospira continues to investigate manufacturing process improvements. | Reverified 6/8/2012 |
| Baxter (Intralipid Emulsion) Customer Service: (1-888-229-0001) | Baxter now has adequate supply available to meet demand. | Baxter has the following Intralipid emulsions available through normal distribution: 20% 100 mL (NDC 00338-0519-48) 20% 250 mL (NDC 00338-0519-02) 20% 500 mL (NDC 00338-0519-03) 20% 1000 mL (NDC 00338-0519-04) 30% 500 mL (NDC 00338-0520-03) | Reverified 4/30/2012 |
| Company | Products | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Teva Customer Service: (888)838-2872 | 30 mg 30 count (NDC 00555-0071-01) 100 count (NDC 00555-0071-02) 1000 count (NDC 00555-0071-05) | 30mg, 30 count and 1000 count presentations are available. 30 mg, 30 count will remain in low inventory until 4Q12. | Manufacturing delays | Reverified 6/4/2012 | |
| 100 mg 100 count (NDC 00555-0066-02) 1000 count (NDC 00555-0066-05) | 100 mg, 100 count and 1000 count are expected to be available in May 2012. | ||||
| Sandoz Customer Service: 1-609-627-8500 | (300 mg - 30s - 00185-4350-30, 100s - 00185-4350-01, 1000s - 00185-4350-10; 100mg - 30s - 00185-4351-30, 100s - 00185-4351-01, 1000s - 00185-4351-10) | 100 mg product currently available.
| API supply issues | Reverified 6/7/2012 | |
| VersaPharm Service: 1-800-548-0700 | (300 mg - 30s - 61748-0013-30, 100s - 61748-0013-01, 1000s - 61748-0013-10; 100mg - 100s - 61748-0016-01) | Information pending |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Bedford Customer Service | 15 mg/mL 1 mL vial, 10 count (NDC 55390-0480-01) | Bedford has all presentations of ketorolac injection on back order and the company cannot estimate a release date | Manufacturing delays | ||
| 30 mg/mL 1 mL vial, 10 count (NDC 55390-0481-01) | |||||
| 30 mg/mL 10 mL vial, 10 count (NDC 55390-0481-10) | |||||
| American Regent/Luitpold 1-800-645-1706 | 15 mg/mL 1 mL vial, 25 count (NDC 00517-0601-25) | Unavailable | American Regent/Luitpold is not manufacturing Ketorolac Tromethamine Injection, USP | Revised 6/8/2012 | |
| 30 mg/mL 1 mL vial, 25 count (NDC 00517-0801-25) | |||||
| 30 mg/mL 2 mL vial for intramuscular use, 25 count (NDC 00517-0902-25) | |||||
| Wockhardt Customer Service: 1-800-346-6854 | 30 mg/mL 1 mL vial, 10 count (NDC 64679-0758-04) | Wockhardt is presently experiencing intermittent releases throughout the month | Revised 6/14/2012 | ||
| 30 mg/mL 1 mL vial, 25 count (NDC 64679-0758-01) | |||||
| 30 mg/mL 2 mL vial, 10 count (NDC 64679-0758-06) | |||||
| 30 mg/mL 2 mL vial, 25 count (NDC 64679-0758-02) | |||||
| 15 mg/mL 1 mL vial, 10 count (NDC 64679-0757-02) | Presently on backorder. An estimated release date is in the latter part of July. | ||||
| 15 mg/mL 1 mL vial, 25 count (NDC 64679-0757-01) | |||||
APP | 15 mg/mL 1 mL vial, 25 count (NDC 63323-0161-01) | APP has all presentations of ketorolac injection on back order and the company cannot estimate a release date. | Raw material supply | Reverified 5/25/2012 | |
| 30 mg/mL 1 mL vial, 25 count (NDC 63323-0162-01) | |||||
| 30 mg/mL 2 mL vial for intramuscular injection, 25 count (NDC 63323-0162-02) | |||||
Hospira, Inc. | 15 mg/mL; 1 mL vial (NDC 0409-3793-01) | Next delivery June | 15 mg/mL; 1 mL Carpuject (NDC 0409-2288-31) and 30 mg/mL; 2 mL Carpuject | Higher than anticipated market demand; Manufacturing delay. | Revised 6/8/2012 |
| 15 mg/mL; 1 mL Carpuject (NDC 0409-2288-31) | Suspended production | ||||
| 30 mg/mL; 1mL vial (NDC 0409-3795-01) | Next delivery June | ||||
| 30 mg/mL; 1 mL Carpuject (NDC 0409-2287-31) | Next delivery June | ||||
| 30 mg/mL; 2 mL Carpuject (NDC 0409-2287-61) | Suspended production | ||||
| 60 mg/mL; 2 ml vial (NDC 0409-3796-01) | Next delivery June |
Leucovorin Calcium Lyophilized Powder for Injection
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
Bedford Laboratories
50 mg (NDC 55390-0005-10); 100 mg (NDC 55390-0052-10); 200 mg (NDC 55390-0053-01) 350 mg (NDC 55390-0054-01); 500 mg?50 mL solution( NDC 55390-0009-01) | Manufacturing delays | Bedford Laboratories has 50 mg, 100 mg, and 350 mg powder for injection available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. The 500 mg/50 mL solution and 200 mg powder for injection are pending release with release date yet to be determined. Availability of products is updated on the Bedford Laboratories website. | Revised 4/10/2012 |
| Teva Pharmaceuticals 1-800-545-8800 | Manufacturing delays | Teva, in conjunction with the FDA, is initiating a temporary importation of Leucovorin Calcium Folinate Solution for Injection, to the United States market to address the current shortage. See Dear Healthcare Professional letter (PDF 692KB) for additional information. Teva has limited inventory available for drop shipment only at this time. | Reverified 6/4/2012 |
| APP Pharmaceuticals 1-888-386-1300 | Increased demand | APP is currently back-ordered due to increased demand. Intermittent releases are being allocated. (NDC# 63323-710-50 for the 200mg SDV and NDC# 63323-711-00 for the 500mg SDV). | Reverified 5/25/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Teva 1-800-545-8800 | 1 mg/0.2 ml (NDC 00703-4014-18) | Teva has Leuprolide Injection on backorder. Teva anticipates product availability in Q412 | Manufacturing Delays | Reverified 6/4/2012 | |
| Sandoz 1-609-627-8500 | 1 mg/0.2 ml (NDC 00185-7400-85) | Product currently unavailable. We will continue to provide updates as further information becomes available. | Manufacturing site availability | Reverified 6/7/2012 | |
| Caraco 313-871-8400 | 1 mg/0.2 ml (NDC 41616-0936-40) | On intermittent backorder. | Increase in demand |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Akorn Pharmaceuticals 1-800-932-5676 | 25 mg/mL, 20 mL vial (NDC 17478-0107-20) | 20 mL (NDC 17478-0107-20)-Readily available 30 mL (NDC 1748-0107-30)-Readily available | Increased Demand | Reverified 4/27/2012 | |
| 25 mg/mL, 30 mL vial (NDC 17478-0107-30) | |||||
| Sagent pharmaceuticals, Inc. 1-866-625-1618 | 250 mg_50 mL Premix Bag NDC 25021-132-81 | Sagent has both presentations of the Levofloxacin Injection vials available.
Sagent has all 3 strengths for premix bags available for contracted customers only |
| N/A | Reverified 6/11/2012 |
| 500 mg_100 mL Premix Bag NDC 25021-132-82 | |||||
| 750 mg_150 mL Premix Bag NDC 25021-132-83 | |||||
| Sandoz Customer Service: 1-609-627-8500 | 250 mg in 50 mL Dextrose 5%, premix bag (NDC 00781-3341-09) | Sandoz has all levofloxacin presentations on back order and releasing product as it becomes available. | Manufacturing delays due to limited API | Reverified 6/7/2012 | |
| 500 mg in 100 mL Dextrose 5%, premix bag (NDC 00781-3342-09) | |||||
| 750 mg in 150 mL Dextrose 5%, premix bag (NDC 00781-3343-09) |
Levoleucovorin (Fusilev) 50 mg single use vials (updated 7/7/2011)
| Company/Products | Reason | Related Information |
|---|---|---|
| Spectrum Pharmaceuticals 1-877-387-4538 or 1-877-FUSILEV | Fusilev (levoleucovorin) for Injection 50 mg vials (NDC 68152-101-00) are available from Spectrum Pharmaceuticals in ample quantities. Based upon the current and anticipated inventory, Spectrum Pharmaceuticals is able to meet all present and future demand. Please call the Company directly at 1-877-387-4538 to obtain Fusilev which is now approved for CRC. Reminder: There is potential for dosing errors when interchanging leucovorin and levoleucovorin (Fusilev). The dose of levoleucovorin (Fusilev) is one-half the dose of racemic leucovorin injection (e.g., levoleucovorin [Fusilev] 7.5 mg = racemic leucovorin 15 mg). For more information visit: Spectrum Pharmaceuticals |
Lidocaine Hydrochloride Injection (Initial Posting Date) - 2/22/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP Customer Service: 1-888-386-1300 | Lidocaine 0.5% Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57) | All lidocaine and Xylocaine presentations are on intermittent back order and will be released as the product becomes available. | Manufacturing delay | Reverified 5/25/2012 | |
| Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57) | |||||
| Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02) | |||||
| Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10) | |||||
| Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27) | |||||
| Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31) | |||||
| Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97) | |||||
| Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91) | |||||
| Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02) | |||||
| Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05) | |||||
| Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17) | |||||
| Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27) | |||||
| Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57) | |||||
| Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10) | |||||
| Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20)-NDC discontinued | |||||
| Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50) – NDC discontinued | |||||
| Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27) | |||||
| Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07) | |||||
| Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97) | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 0.5% w/EPI 1:200,000; 50 mL vial (NDC 0409-3177-01) | Ample supply available | Available presentations: Please check with your wholesaler for available inventory | Manufacturing delay | Revised 6/1/2012 |
| 1% w/EPI 1:100,000; 30 mL vial (NDC 0409-3178-02 | Ample levels of inventory available to meet market demand. | ||||
| 1% w/EPI 1:100,000; 50 mL vial (NDC 0409-3178-03) | Next delivery May | ||||
| 1.5% w/EPI 1:200,000; 5 mL amp (NDC 0409-1209-65) | Next delivery May | ||||
| 1.5% w/EPI 1:200,000; 30 mL amp (NDC 0409-3181-01) | Ample supply available | ||||
| 2% w/EPI 1:100,000; 20 mL vial (NDC 0409-3182-01) | Next delivery May | ||||
| 2% w/EPI 1:100,000; 30 mL vial (NDC 0409-3182-02) | Next delivery May | ||||
| 2% w/EPI 1:100,000; 50 mL vial (NDC 0409-3182-03) | Next delivery May | ||||
| .0.5%; 50 mL FT vial (NDC 0409-4275-01) | Next delivery May | ||||
| 0.5%; 50 mL TT vial (NDC 0409-4278-01) | Next delivery May | ||||
| 1%; 2 mL amp (NDC 0409-4713-32) | Next delivery May | ||||
| 1%; 20 mL vial (NDC 0409-4276-01) | Next delivery May | ||||
| 1%; 30 mL vial (NDC 0409-4279-02) | Next delivery May | ||||
| 1%; 50 mL vial (NDC 0409-4276-02) | Next delivery May | ||||
| 1%; 30 mL Sterile Pack vial (NDC 0409-4270-01) | Next delivery May | ||||
| 2%; 2 mL amp(NDC 0409-4282-01) | Next delivery May | ||||
| 2%; 10 mL amp (NDC 0409-4282-02) | Next delivery May | ||||
| 2%; 5 mL vial (NDC 0409-2066-05) | Next delivery May | ||||
| 2%; 20 mL vial (NDC 0409-4277-01) | Next delivery May | ||||
| 2%; 50 mL vial (NDC 0409-4277-02) | Next delivery May | ||||
| 4%; 5 mL amp (NDC 0409-4283-01) | Next delivery May | ||||
| Product 1.5% w/EPI 1:200,000; 5 mL amp (NDC 0409-1209-65) | Next delivery May | ||||
| 1.5% w/EPI 1:200,000; 30 mL amp (NDC 0409-3181-01) | Ample supply available | ||||
| 2%; 5mL Ansyr syringe (NDC 0409-1323-05) | Next delivery May | ||||
| LTA Kit; Lidocaine Topical Solution 4%; 4 mL syringe kit (NDC 0409-4698) | Next delivery TBD | ||||
| Amphastar Pharmaceuticals, Inc. Customer Service: 1-800-423-4136 | Lidocaine HCl Inj. USP, 2%, 5mL Luer-Jet Prefilled Syringe (NDC 0548-3390-00)
(*New NDC# 76329-3390-1) | Amphastar will regularly release products. | Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues. | Increased Demand | Revised 6/5/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
West-Ward Pharmaceuticals Customer Service: | Ativan (lorazepam) Injection 2 mg/mL, 1 mL vial 2 mg/mL, 10 mL vial, (NDC 60977-116-02) 4 mg/mL, 1 mL vial 4 mg/mL, 10 mL vial, (NDC 60977-113-02) | West-Ward is currently experiencing a backorder situation on all Ativan and Lorazepam codes. Manufacturing has been increased to meet product demand. Multiple lots of all codes are projected to be manufactured, released and available in the April – May 2012 timeframe. A few additional lots are also projected to be available in June 2012. | Increase in product demand due to market supply issues. | Revised 4/24/2012 | |
Lorazepam Injection, USP 2 mg/mL, 1 mL vial 2 mg/mL, 10 mL vial, (NDC 10019-102-10) 4 mg/mL, 1 mL vial 4 mg/mL, 10 mL vial, (NDC 10019-103-10) | |||||
| Bedford Laboratories Customer Service: 1-800-562-4797 | 2 mg/mL, 1 mL vial (NDC 55390-0168-10), 10 mL vial (NDC 55390-0170-10) | Product Discontinued: Bedford currently has all presentations discontinued. | Not currrently marketed. | ||
Hospira Inc. Customer Service: | 2 mg/mL; 1 mL vial | Next delivery June | Please check with your wholesaler for available inventory. | Manufacturing delay | Revised 6/8/2012 |
| 2 mg/mL; 10 mL vial (NDC 0409-6780-02) | Next delivery June | ||||
2 mg/mL; 1 mL Carpuject syringe | Next delivery June | ||||
2 mg/mL; 1 mL iSecure syringe | Discontinued | ||||
4 mg/mL; 1 mL vial | Next delivery June | ||||
4 mg/mL; 10 mL vial | Next delivery July | ||||
| 4 mg/mL; 1 mL Carpuject syringe (NDC 0409-1539-31) | Temporarily unavailable | ||||
| Akorn: 847-279-6100 | N/A | Akorn has Lorazepam injection 2 mg/mL, 1 mL vials on intermittent back order and are filling direct orders and shipping to wholesalers as product becomes available. | Reverified 4/27/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 500 mg/mL, 2 mL vial (NDC 63323-0064-02) | APP has all presentations on intermittent back order and the company is releasing the product as it becomes available. | Check wholesalers for inventory. | Increased demand for the product. | Revised 5/29/2012 |
| 500 mg/mL, 10 mL vial (NDC 63323-0064-10) | |||||
| 500 mg/mL, 20 mL vial (NDC 63323-0064-20) | |||||
| 500 mg/mL, 50 mL vial (NDC 63323-0064-50) | |||||
| American Regent/Luitpold 1-800-645-1706 | 500 mg/mL, 2 mL vial (NDC 00517-2602-25) | Unavailable | Currently not releasing. | Revised 6/8/2012 | |
| 500 mg/mL, 10 mL vial (NDC 00517-2610-25) | |||||
| 500 mg/mL, 50 mL vial (NDC 00517-2650-25) | |||||
| Hospira, Inc. Customer Service 1-877-946-7747
| 50%; 20 mL vial (NDC 0409-2168-02) | Next delivery June | Please check with your wholesaler for available inventory. | Manufacturing delay | Reverified 5/29/2012 |
50 %; 10 mL Ansyr syringe (NDC 0409-1754-10) | Next delivery October | ||||
40 mg/mL-water; 50 mL bag (NDC 0409-6729-24) | Ample supplies available | ||||
40 mg/mL-water; 100 mL bag (NDC 0409-6729-23) | Ample supplies available | ||||
40 mg/mL-water; 500 mL bag (NDC 0409-6729-03) | Ample supplies available | ||||
40 mg/mL-water; 1000 mL bag (NDC 0409-6729-09) | Ample supplies available | ||||
10 mg/mL-dextrose; 100 mL bag (NDC 0409-6727-23) | Ample supplies available | ||||
80 mg/mL-water; 50 mL bag (NDC 0409-6730-13) | Ample supplies available |
Mannitol Injection (Initial Posting Date) - 12/21/2011
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP Customer Service: 1-888-386-1300 | 250 mg/mL, 50 mL vial, 25 count (NDC 63323-0024-25) | APP has increased production and will have intermittent releases of product. | Increase in product demand | Reverified 5/25/2012 | |
| B. Braun Medical Inc. Customer Service: 1-800-227-2862 | 20% Mannitol Injection USP L5781 500 mL flexible plastic container NDC 0264-7578-10 | B. Braun has increased manufacturing forecast due to an increase in demand. B. Braun has inventory of the 500 mL and 250 mL product available and is scheduled to have additional product available mid February 2012. | No shortage | ||
| L5782 250 mL flexible plastic container NDC 0264-7578-20 | |||||
| Hosprira, Inc. Customer Service 1-877-946-7747 | 25%; 50 mL vial (NDC 0409-4031-01) | Next delivery June | Please check with your wholesaler for all available inventory. | Manufacturing delay | Reverified 6/8/2012 |
| 20%; 250 mL container (NDC 0409-7715-02) | Next delivery 2012 | ||||
| 20%; 500 mL container (NDC 0409-7715-03) | Next delivery 2012 | ||||
| American Regent/Luitpold 1-800-645-1760 | 25%, 50 mL vial NDC 0517-4050-25 | Unavailable | Currently not releasing. | Revised 6/8/2012 | |
| Baxter Customer Service: 1-800-ANA-DRUG (1-800-262-3784) | 20% OSMITROL Injection (20% Mannitol Injection, USP). NDC: 0338-0357-02 | Product Available | Reverified 4/30/2012 | ||
| 20% OSMITROL Injection (20% Mannitol Injection, USP). NDC: 0338-0357-03 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Sagent Pharmaceticals: 1-866-625-1618 | 10 mL vials, 1 count (NDC 25021-0201-10) | Sagent has both presentations of mesna available. | Manufacturing delays | Reverified 6/11/2012 | |
| 10 mL vials, 10 count (NDC 25021-0201-11) | |||||
| APP: 1-888-386-1300 | 10 mL vial, 1 count (NDC 63323-0773-11) | APP has available both 10 mL vials in the 1 count and 10 count. | Available | Reverified 5/25/2012 | |
| 10 mL vial, 10 count (NDC 63323-0773-10) | |||||
| Bedford: 1-800-562-4797 | 10 mL vial, 1 count (NDC 55390-0045-01) | Bedford has mesna injection on back order and the company cannot estimate a release date. | Manufacturing delays | ||
| Teva: 1-800-545-8800 | 10 mL vial, 10 count (NDC 00703-4805-03) | Teva has Mesna Injection on back order. Teva anticipates product availability in 4Q12 | Manufacturing delays | Reverified 6/4/2012 | |
| Baxter Customer Service: 1-800-ANA-DRUG (1-800-262-3784) | Mesna 10 mL vial, 1 count (NDC 10019-0953-01) | All products are available | Available | Reverified 4/30/2012 | |
| 10 mL vial, 10 count (NDC 10019-0953-02) | |||||
| Mesnex 100 mg/mL Injection, 10 mL vial, 1 count (NDC 00338-1305-01) | |||||
| 10 mL vial, 10 count (NDC 00338-1305-03 | |||||
Mylan Institutional | 100 mg/ml; packaged in 1,000 mg/10 ml Multiple- dose vials | Available. | Available | Reverified 5/30/2012 |
| Company | Product | Availability Information | Notes | Reasson | Date Updated |
|---|---|---|---|---|---|
APP Customer Service
| 25 mg/mL; 10 mL vial (NDC 63323-0123-10) | Available | Increased demand | Reverified 5/25/2012 | |
| 1 g, SDV, Lyo (NDC 63323-0122-50) | Available | ||||
| Bedford Customer Service 1-800-562-4797 | 25 mg/mL; 2 mL vial; Preservative Free (NDC 55390-0031-10) | Bedford Laboratories has preservative-free 1 gram lyophilized powder for injection (NDC 55390-0143-01) available in limited quantities.. Once this supply is depleted, the next estimated release dates are unknown. Other presentations are out of stock and the company cannot estimate a release date. Production is pending as capacity permits. Availability of products is updated on the Bedford Laboratories website. | Manufacturing delays | Revised 4/10/2012 | |
| 25 mg/mL; 4 mL vial; Preservative Free (NDC 55390-0032-10) | |||||
| 25 mg/mL; 8 mL vial; Preservative Free (NDC 55390-0033-10) | |||||
| 25 mg/mL; 10 mL vial; Preservative Free (NDC 55390-0034-10) | |||||
| Methotrexate lyophilized powder for injection 1 gram vial; (NDC 55390-0143-01 | |||||
| Hospira, Inc. Customer Service 1-877-946-7747 | 25 mg/mL; 2 mL vial With Preservative (NDC 61703-350-38) | Next delivery July. Hospira is releasing direct customer orders only. | Please check with your wholesaler for all available inventory. | Other manufacturer shortage/withdrawal | Reverified 6/8/2012 |
| 25 mg/mL; 40 mL vial; Preservative Free (NDC 61703-408-41) | Ample levels of inventory to support market demand. | ||||
| Mylan Institutional 1-888-258-4199 | 25mg/ml; 2ml vial Preservative Free (NDC 10139-0062-02) | Shipping to wholesalers. Please check with your wholesaler for availability. | As additional product becomes available, it will continue to be allocated via drop ship orders. | Significant increase in demand. | Revised 5/30/2012 |
| 25 mg/ml; 10ml vial Preservative Free (NDC 10139-0062-10) | |||||
| 25 mg/ml; 40ml vial Preservative Free (NDC 10139-0062-40) | Currently unavailable | ||||
| Sandoz Customer Service: 1-609-627-8500 | 25mg/ml; 2ml vial Preservative Free (NDC 66758-0040-02) | Temporarily discontinued the 2ml vial presentation. |
| Manufacturing delays | Reverified 6/7/2012 |
| 25mg/ml; 10ml vial Preservative Free (NDC 66758-0040-08) | Temporarily discontinued the 10 mL vial presentation | ||||
| 25mg/ml; 40ml vial Preservative Free (NDC 66758-0041-01) | Experiencing a back order on 40ml vials. |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Sandoz Customer Service: 1-609-627-8500 | 5 mg, 100s (NDC 00781-5748-01) | Capacity constraints and receiving API orders. | Revised 6/7/2012 | ||
| 10 mg, 100s (NDC 00781-5749-01) | |||||
| 20 mg, 100s (NDC 00781-5753-01) | |||||
| 20 mg, 100s (NDC 00781-5754-01) | |||||
Mallinckrodt Customer Service:
| 5 mg (100s - NDC 00406-1121-01; 1000s - NDC 00406-1121-10) 10 mg (100s - NDC 00406-1122-01; 1000s - NDC 00406-1122-10) 20 mg (100s - NDC 00406-1124-01; 1000s - NDC 00406-1124-10) Methylin ER, 10 mg (100s - NDC 00406-1423-01) and 20 mg (100s - NDC 00406-1451-01)
Methylin ER 20 mg (100s - NDC 00406-1451-01) | All strengths of methylphenidate IR and ER tablets are expected to be available by mid-June to meet historical demand. |
| Manufacturing delays | Revised 5/18/2012 |
| UCB Customer Service: 1-800-477-7877 | 5 mg (100s - NDC 53014-0531-07), 10 mg (100s - NDC 53014-0530-07), and 20 mg (100s - NDC 53014-0532-07)
Metadate ER Tablets, 20 mg (100s - NDC 53014-0594-07)
Metadate CD, 10 mg (100s - NDC 53014-0579-07), 20 mg (100s - NDC 53014-0580-07), 30 mg (100s - NDC 53014-0581-07), 40 mg (100s - NDC 53014-0582-07), 50 mg (100s - NDC 53014-0583-07), and 60 mg (100s - NDC 53014-0584-07) | UCB is in stock in all strengths of our methylphenidate products (IR, ER, and CD) and presentations. |
| N/A | Reverified 6/12/2012 |
| Watson Customer Service: (973) 355-8300 | 5 mg (100s - NDC 00591-5882-01), 10 mg (100s - NDC 00591-5883-01), and 20 mg (100s - NDC 00591-5884-01) | Watson has all 3 strengths available for contracted customers only. | n/a | ||
Noven Customer Service: Daytrana (Methylphenidate Transdermal System) | 10 mg (30s - NDC 68968-5552-3) 15 mg (30s - NDC 68968-5553-3) 20 mg (30s - NDC 68968-5554-3) 30 mg (30s - NDC 68968-5555-3) | Currently all product is available |
| Not applicable |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| American Regent, Inc./Luitpold: 1-800-645-1706 | 50 mg/mL, 5 mL vial (NDC 00517-8905-10) | Unavailable | Currently not releasing. | Revised 6/8/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 5 mg/mL 2 mL vials (NDC 00409-3414-01) | Next delivery June | Hospira discontinued Metoclopramide Carpuject syringes in May, 2009 and ampules in February, 2010. Please check with your wholesaler for available inventory. | Manufacturing delay | Revised 6/8/2012 |
| Teva Pharmaceuticals 1-800-545-8800 | 5 mg/mL, 2 mL vial, 25 count (NDC 00703-4502-04) | Teva has made a business decision to discontinue this product. See the Dear Valued Customer Letter (PDF - 32KB) | Reverified 6/4/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 1 mg/mL, 2 mL vial, 25 count (NDC 63323-0411-12) | APP has midazolam injection on intermittent back order and the company is releasing product on a regular basis. Check with wholesalers for inventory. | Increased demand | Reverified 5/25/2012 | |
| 1 mg/mL, 5 mL vial, 25 count (NDC 63323-0411-25) | |||||
| 1 mg/mL, 10 mL vial, 10 count (NDC 63323-0411-10) | |||||
| 5 mg/mL, 5 mL vial, 10 count (NDC 63323-0412-05) | |||||
| 5 mg/mL, 10 mL vial, 10 count (NDC 63323-0412-10) | |||||
| 5 mg/mL, 2 mL vial, 25 count (NDC 63323-0412-02) | |||||
| 5 mg/mL, 1 mL fill in 2 mL vial, 25 count (NDC 63323-0412-25) | |||||
| Bedford Customer Service: 1-800-562-4797 | 1 mg/mL, 2 mL preservative-free vial, 10 count (NDC 55390-0137-02) | Bedford has all midazolam presentations on back order and the company cannot estimate a release date. | The 1 mg/mL 2 mL and 10 mL vials and the 5 mg/mL 2 mL (1 mL fill), 5 mL and 10 mL vials vials are pending release while the other presentations will not be manufactured until capacity permits.
Bedford Laboratories has temporarily suspended the distribution of Ben Venue Laboratories manufactured products. Availability of products is updated on the Bedford Laboratories website | Temporary suspension of manufacturing. | |
| 1 mg/mL, 5 mL preservative-free vial, 10 count (NDC 55390-0137-05) | |||||
| 1 mg/mL, 10 mL vial, 10 count (NDC 55390-0125-10) | |||||
| 5 mg/mL, 2 mL preservative-free vial, 10 count (NDC 55390-0138-02) | |||||
| 5 mg/mL, 1 mL preservative-free, in 2 mL vial, 10 count (NDC 55390-0138-01) | |||||
| 5 mg/mL, 5 mL vial, 10 count (NDC 55390-0126-05) | |||||
| 5 mg/mL, 10 mL vial, 10 count (NDC 55390-0126-10) | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1 mg/mL, 2 mL preservative-free Luer-lock syringe (NDC 0409-2306-62) | Next delivery August | Hospira discontinued the following products: | Other manufacturer shortage/withdrawal; Manufacturing delay; Quality improvement activities. | Revised 6/8/2012 |
| 1 mg/mL, 2 mL preservative-free vial (NDC 0409-2305-17) | Next delivery June | ||||
| 1 mg/mL, 5 mL preservative-free vial (NDC 0409-2305-05) | Next delivery June | ||||
| 1 mg/mL, 2 mL preservative-free iSecure syringe (NDC 0409-2306-12) | Next delivery August | ||||
| 1 mg/mL, 10 mL vial (NDC 0409-2587-05) | Next delivery June | ||||
| 5 mg/mL, 1 mL preservative-free vial (NDC 0409-2308-01) | Next delivery July | ||||
| 5 mg/mL, 5 mL vial (NDC 0409-2596-03) | Next delivery June | ||||
| 5 mg/mL, 10 mL vial (NDC 0409-2596-05) | Next delivery June | ||||
| 5 mg/mL, 1 mL preservative-free Luer-Lock syringe (NDC 0409-2307-60) | Next delivery 2013 | ||||
| 5 mg/mL, 2 mL preservative-free vial (NDC 0409-2308-02) | Next delivery July | ||||
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 (Formerly a Baxter Product) | 2 mL vial, 1 mg/mL (NDC 0641-6057-25)25 pack (NDC 0641-6057-10)10 pack | West-Ward has accelerated production and will have units of all presentations available for release in the June – July 2012 timeframe. | West-Ward is currently experiencing a backorder situation on all of the Midazolam codes. Product will be made available as it is released. | Increase in product demand | Revised 6/6/2012 |
5 mL vial, 1 mg/mL (NDC 0641-6059-10) | |||||
| 10 mL vial, 1 mg/mL (NDC 0641-6056-10) | |||||
1 mL vial, 5 mg/mL (NDC 0641-6061-25)25 pack(NDC 0641-6061-10)10 pack | |||||
2 mL vial, 5 mg/mL (NDC 0641-6063-25)25 pack (NDC 0641-6063-10)10 pack | |||||
10 mL vial, 5 mg/mL (NDC 0641-6060-10)
| |||||
| Akorn: 847-279-6100 | All presentations- Re-launching late June. | N/A | Reverified 4/27/2012 | ||
| Sagent Pharmaceuticals, Inc. 1-866-625-1618 | 2 mg/2 mL vial (preservative-free), NDC 25021-655-02 | Sagent has all presentations of midazolam on allocation. | Product Available | Reverified 6/11/2012 | |
| 5 mg/5 mL vial, (preservative-free) NDC 25021-655-05 | |||||
| 5 mg/mL vial, (preservative-free) NDC 25021-656-01 | |||||
| 10 mg/2 mL vial, (preservative-free) NDC 25021-656-02 | |||||
| 10 mg/10 mL vial, NDC 25021-660-10 | |||||
| 25 mg/5 mL vial, NDC 25021-661-05 | |||||
| 50 mg/10 mL vial, NDC 25021-661-10 |
Mitomycin Powder for Injection
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Accord Customer Service: 919-941-7879 | 5 mg (NDC 16729-0115-05) | Available at this time. | Orders are being shipped out | Revised 6/14/2012 | |
| 20 mg (NDC 16729-0108-11) | Stock arriving at warehouse 6/15/2012 and will be available for shipping. | ||||
| 40 mg (NDC 16729-0116-38) | Product shipped out the week of 6/11/2012. Additional coming in, mid of July 2012 | ||||
| Bedford Laboratories: 1-800-562-4797 | 5 mg (NDC 55390-0251-01) | Bedford Laboratories has 5 mg and 20 mg available in limited quantities. | Bedford Laboratories is out of stock and the company cannot estimate a release date. Production is pending as capacity permits. Availability of products is updated on the Bedford Laboratories website. | Manufacturing delays | Revised 4/10/2012 |
| 20 mg (NDC 55390-0252-01) | |||||
| 40 mg (NDC 55390-0253-01) |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1 mg/mL, 30 mL PCA vial (NDC 0409-2029-02) | Hospira is providing through direct customers only. Next delivery June. | Please check with your wholesaler for available inventory. | Manufacturing delay | Revised 6/8/2012 |
| 5 mg/mL; 30 mL PCA vial (NDC 0409-6028-04) | Next delivery June | ||||
| 2 mg/mL; 1 mL Carpuject (NDC 0409-1762-30) | Next delivery June | ||||
| 4 mg/mL; 1 mL Carpuject (NDC 0409-1258-30) | Next delivery June | ||||
| 8 mg/mL; 1 mL Carpuject (NDC 0409-1260-69) | Next delivery June | ||||
| 10 mg/mL; 1 mL Carpuject (NDC 0409-1261-30) | Next delivery June | ||||
| 15 mg/mL; 1 mL Carpuject syringes (NDC 0409-1264-31) | Next delivery June | ||||
| 50 mg/mL, 20 mL vial (NDC 0409-1134-03) | Available | ||||
| 50 mg/mL, 50 mL vial (NDC 0409-1134-05) | Available | ||||
| 25 mg/mL; 4 mL Add-vantage vial (NDC 0409-6177-14) | Next delivery August | ||||
| 25 mg/mL, 10 mL Add-Vantage vial (NDC 0409-6179-14) | Next delivery August | ||||
| Amphastar Pharmaceuticals Inc. Customer Service: 1-800-423-4136 | Morphine Sulfate Inj. USP, 1mg/mL, 30mL PCA Vial (NDC 0548-1911-25) | Available | N/A | Available | Revised 6/5/2012 |
| West-Ward Customer Service: 1-888-229-0001
| 1 mL vial, 5 mg/mL (NDC 0641-6073-25) | On backorder | West-Ward has accelerated production on all morphine codes and is projecting to have multiple lots available by the end of May.
Additional lots are also scheduled to be manufactured with an estimated availability in the June - July 2012 timeframe. | Increase in product demand | Revised 4/24/2012 |
| 1 mL vial, 8 mg/mL (NDC 0641-6075-25) | On backorder | ||||
| 1 mL vial, 10 mg/mL) (NDC 0641-6070-25) | On backorder | ||||
| 10mL vial, 10 mg/mL (NDC 0641-6068-01) | On backorder | ||||
| 1 mL vial, 15 mg/mL (NDC 0641-6071-25) | Limited availability | ||||
| 20 mL vial, 15 mg/mL (NDC 0641-6072-01) | On backorder | ||||
Morphine Sulfate Injection (Preservative Free)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 Astramorph (preservative-free) Inj | 0.5 mg/mL 2 mL ampule, 10 count (NDC 63323-0291-80) | APP has preservative-free Astramorph 0.5 mg/mL 2 mL ampules, 1 mg/mL 2 mL ampules and 10 mL ampules, and 0.5 mg/mL 10 mL vials on back order with an estimated release date in fourth quarter of 2012 | Change in manufacturing sites | Reverified 5/25/2012 | |
| 0.5 mg/mL 10 mL vial, 5 count (NDC 63323-0291-10) | |||||
| 1 mg/mL 2 mL ampule, 10 count (NDC 63323-0292-80) | |||||
| 1 mg/mL, 10 mL vial (NDC 63323-0292-10) | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 0.5 mg/mL; 10 mL vial (NDC 0409-3814-12) | Next delivery July |
| Manufacturing delay | Revised 6/8/2012 |
| 1 mg/mL; 10 mL vial (NDC 0409-3815-12) | Next delivery July | ||||
| 25 mg/mL; 1 mL vial (NDC 0409-1135-02) | Next delivery July | ||||
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 (Formerly a Baxter Product) | Infumorph 20 mL ampul, 10 mg/mL (NDC 0641-6039-01) | situation on most of the Infumorph and Duramorph codes.
West-Ward has accelerated production on all preservative-free morphine codes and will have the following products available.
Product will be made available as it is released. | Increase in product demand | Revised 5/31/2012 | |
Infumorph 20 mL ampul, 25 mg/mL | The 20 mL ampul, 25 mg/mL, is available in very limited quantities. Lots of both Infumorph codes are scheduled for production and will be available for release by the end of June 2012. | ||||
| Duramorph 10 mL ampul, 1 mg/mL) (NDC 0641-6019-10) | Several lots of each Duramorph code are scheduled for manufacturing in June 2012. | ||||
Duramorph 10mL ampul, 0.5 mg/mL |
Multi-Vitamin Infusion (Adult and pediatric)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Hospira , Inc. Customer Service 1-877-946-7747 MVI-12 Adult; 10 mL vial (NDC 61703-423-81) | Production of Adult formulations temporarily suspended. | MVI Pediatric 5 mL vial (NDC 61703-421-53): ample levels of inventory to support market demand. | Reverified 6/8/2012 |
Baxter (Infuvite adult and pediatric IV solution)
INFUVITE Pediatric, Multiple Vitamins for Injection. Single Dose package. (NDC 54643-5646-1)
| Manufacturing delays | Baxter is the distributor of INFUVITE Multi Vitamins. Baxter has these multi-vitamin products on allocation and is working with the manufacturer to maximize the availability of INFUVITE Multi Vitamins.
| Reverified 5/11/2012 |
Mustargen (mechlorethamine HCl) injection (updated 1/6/2012)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Lundbeck Inc. Customer service number: 1-888-514-5204 | See Related Information | Lundbeck has transferred production of Mustargen to a new manufacturing site and is in the process of securing supplies to reintroduce the product
| Revised 5/4/2012 |
Nalbuphine HCl Injection (Initial Posting - 5/15/2012)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 10 mg/mL; 1 mL ampule (NDC 0409-1463-01) 10 mg/mL; 10 mL vial (NDC 0409-1464-01) 20 mg/mL; 1 mL ampule (NDC 0409-1465-01) 20 mg/mL; 10 mL vial (NDC 0409-1467-01) | Manufacturing delay | Product 10 mg/mL; 1 mL ampule (NDC 0409-1463-01): next delivery July. Product 10 mg/mL; 10 mL vial (NDC 0409-1464-01): next delivery July. Product 20 mg/mL; 1 mL ampule (NDC 0409-1465-01): next delivery July. Product 20 mg/mL; 10 mL vial (NDC 0409-1467-01): next delivery July. Please check with your wholesaler for available inventory. | Reverified 6/8/2012 |
Naloxone Injection (Initial Posting Date) - 2/22/2012
| Company | Product | Availability Information | Notes | Notes | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747
| Naloxone 0.4 mg/mL Injection; 1mL vial (NDC 00409-1215-01) | Next delivery June | Please check with your wholesaler for available inventory. | Manufacturing delay | Reverified 6/8/2012 |
| Naloxone 0.4 mg/mL Injection; 10mL MDV (NDC 00409-1219-01) | Ample supplies available | ||||
| Naloxone 0.4 mg/mL Injection; 1mL in 2mL Carpuject (NDC 00409-1782-69) | Next delivery September | ||||
| Amphastar Pharmaceuticals, Inc. 1-800-423-4136 | Naloxone 1 mg/mL Injection; 2 mL syringes with needles (NDC 00548-1469-00) (*New NDC# 76329-1469-5) | Available | N/A | Available | Revised 6/5/2012 |
Naloxone 1 mg/mL Injection; 2 mL syringes without needles (NDC 00548-3369-00) (*New NDC# 76329-3369-1) |
Naltrexone Oral Tablets (Initial Posting Date) - 2/22/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Mallinckrodt Customer Service: 1-800-325-8888
| 50 mg oral tablets 100 count (NDC 00406-1170-01) | May experience some backorders through July. | Supply recovery continues, but may experience some backorders through July due to increased demand. | Raw material supply | Revised 5/31/2012 |
| 30 count (NDC 00406-1170-03) | |||||
Teva Pharmaceuticals | Naltrexone HCl Tablets, 50 mg 30 count (NDC 00555-0902-01) | Both presentations have inventory available. | Manufacturing Capacity | Reverified 6/4/2012 | |
| Naltrexone HCl Tablets, 50 mg, 100 count (NDC 00555-0902-02) | Both presentations have inventory available. |
Nefazodone Tablets (Initial Posting Date) - 4/16/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Teva Pharmaceuticals | 50 mg, 100 count (NDC 00093-7178-01) | Teva Nefazodone 50 mg is on back order. The company estimates a release date late May 2012. | Availability of API | Reverified 5/18/2012 | |
| 100 mg, 60 count (NDC 00093-1024-06) | |||||
| 150 mg, 60 count (NDC 00093-7113-06) | 100 mg and 150 mg are now in stock. | ||||
| 100 mg and 150 mg are now in stock. |
NeoProfen (ibuprofen lysine) Injection (updated 12/15/2011)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Lundbeck Inc. Customer service number: 1-888-514-5204 | Failure to meet a visible particulate quality specification. | Lundbeck voluntarily recalled NeoProfen as a safety precaution due to ongoingissues at Lundbeck's current contract manufacturer. Lundbeck anticipates NeoProfen to be available in third quarter 2012. | Revised 5/24/2012 |
Neupro (rotigotine transdermal system) (5/5/2010)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| UCB, Inc 800-477-7877 | Neupro (rotigotine transdermal system) | FDA has requested that UCB reformulate Neupro (rotigotine transdermal system) patches. A reformulated version was recently approved by FDA and Neupro will be available in U.S. retail pharmacies in July 2012. If you have additional questions about the status of Neupro, please contact UCB Medical Information at 1-866-822-0068. | UCB has recalled all domestic lots | Reverified 6/12/2012 |
Neurolite, Kit for the Preparation of Technetium Tc99m Bicisate for Injection (Initial Posting Date) – 5/4/2012
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Lantheus Medical Imaging 1-800-299-3431 Neurolite, Kit for the Preparation of Technetium Tc99m Bicisate for Injection 2 kit in 1 package, combination (NDC 11994-006-02) and 5 kit in 1 package, combination (NDC 11994-006-05) | Manufacturing delays | Lantheus has Neurolite® on back order and the company cannot estimate a release date. |
Norethindrone and Ethinyl Estradiol Tablets, USP (Ovcon 50 Tablets) (Initial Posting -4/6/2012)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Warner Chilcott Customer Service 1-877-597-9462 Ovcon 50 Tablets NDC 0430-0585-45 | Manufacturing delays | No estimated date of availability. |
| Company | Product | Availability information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
APP | 4 mg; 2 mL (NDC 63323-0373-02) | APP has Ondansetron 2 mg/mL 2 mL vials on back order with an estimated release date of early June 2012. Check wholesalers for inventory. The 40 mg, 20mL vials are currently available - check wholesalers for inventory. | Increased demand | Reverified 5/25/2012 | |
| 40 mg; 20 mL (NDC 63323-0374-20) | |||||
Bedford 20 mL vial (NDC 55390-0121-01) | 2 mL vials, packages of 10 (NDC 55390-0121-10) - discontinued | Bedford has ondansetron 2 mg/mL 20 mL vials on back order and the company cannot estimate a release date. Bedford Laboratories has multiple products affected by this temporary suspension of manufacturing. Bedford will have the affected, as well as the available products, listed on their website and are updating this information as it changes. The company voluntarily suspended all manufacturing and distribution in mid-November, 2011 on a temporary basis for maintenance and requalification of equipment. Product will become available in stages as production resumes. Bedford discontinued the following products: | Temporary suspension of manufacturing. | ||
| 2 mL Novaplus vials, packages of 10 (NDC 55390-0307-10) - discontinued | |||||
| 20 mL Novaplus vials, packages of 1 (NDC 55390-0307-01) - discontinued | |||||
| Caraco 313-871-8400 | 2 mL ampules (NDC 62756-0181-01) | Caraco temporarily discontinued ondansetron injection | |||
| 20 mL vials (NDC 62756-0182-01) | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 2 mg/mL; 2 mL vials (NDC 0409-4755-03) | Next delivery June | Please check with your wholesaler for available inventory. | Other manufacturer shortage/withdrawal; Quality improvement activities. | Revised 6/8/2012 |
| 2 mg/mL; 20 mL vials (NDC 0409-4759-01) | Next delivery June | ||||
| 0.64 mg/mL; 50 mL bag (32 mg/50 mL) (NDC 0409-4760-24 | Next delivery 2012 | ||||
| West-Ward (formerly Baxter products) Customer Service: | 2 mg/mL, 2 mL vial (NDC 0641-6078-25) | Multiple lots are scheduled for manufacturing and release in June and July 2012. | Backorder. West-Ward has accelerated production and is projecting to have additional units available. Product will be made available as it is released | Increase in product demand. | 5/31/2012 |
2 mg/mL, 20 mL Vial (0641-6079-01) | |||||
| Teva 1-800-545-8800 | 20 mL vials (NDC 00703-7226-01) | Teva discontinued ondansetron 2 mL vials in 5 count packages. Teva has the following presentation on intermittent back-order. These skus will remain on allocation through Q212: 2 mL vials, package of 25 (NDC 00703-7221-04) 20 mL vials, package of 10 (NDC 00703-7226-03) | Reverified 6/4/2012 | ||
| 2 mL vials, packages of 5 (NDC 00703-7221-02) - discontinued | |||||
| GlaxoSmithKline Customer Service: 1-888-825-5249 | Zofran injection, 2 mg/mL, 2 mL vials, packages of 5 (NDC 00173-00442-02) | GlaxoSmithKline has the following available: 20 mL vial (NDC 00173-0442-00) GlaxoSmithKline has discontinued Zofran 2 mL vials | |||
| 20 mL vial (NDC 00173-0442-00) | |||||
Wockhardt Customer Service: | 2 mg/mL, 2 mL vials, package of 5 (NDC 64679-0726-01) | Wockhardt is presently experiencing intermittent releases for the following strengths and sizes of Ondansetron for Injection throughout the month of May 2012. 2 mg/mL, 2 mL vials, package of 5 (NDC 64679-0726-01) 2 mg/mL, 20 mL vials, package of 1 (NDC 64679-0727-01 | Revised 5/15/2012 | ||
| 2 mg/mL, 20 mL vials, package of 1 (NDC 64679-0727-01) | |||||
Pfizer
| Ondansetron 4 mg/2mL x 25 count (preservative fee, latex free) NDC 0069-1340-16 | Pfizer has the following presentations of ondansetron 2 mg/mL available in limited quantities: 2 mL vials, package of 25 (NDC 0069-1340-16) | Reverified 5/21/2012 | ||
| 40mg/20mL x 1 MDV NDC 0069-1340-02 |
Ondansetron Injection 32 mg/50 mL premixed bags
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Claris 32 mg/50 mL (NDC 36000-0014-06) | Pending information | Pending information | |
| Sagent Pharmaceuticals 1-866-625-1618 32 mg/50 mL (NDC 25021-0776-50) - discontinued | Discontinued | Sagent has discontinued their ondansetron premixed bags. | |
| Teva Pharmaceuticals 1-800-545-8800 32 mg/50 mL (NDC 00703-7239-39) | Manufacturing delay | Teva has ondansetron 32 mg/50 mL premixed bags on back order and the company cannot estimate a release date. | Reverified 6/4/2012 |
| Hospira, Inc. Customer Service: 1-877-946-7747 0.64 mg/mL; 50 mL bag | Other manufacturer shortage/withdrawal; Quality improvement activities. | Product 0.64 mg/mL; 50 mL bag (32 mg/50 mL) (NDC 0409-4760-24): next delivery 2012. | Reverified 6/8/2012 |
| Baxter Customer Service: 1-888-229-0001 32 mg/50 mL (NDC 00338-1762-41) | Increase in demand | Baxter has 32 mg/50 mL premixed bags on back order with an estimated release date of June 2012. | Revised 4/30/2012 |
Ontak injection (9/22/2011)
| Company/Products | Reason | Related Information |
|---|---|---|
| Eisai 1-888-422-4743 150 mcg/mL, Eisai | Manufacturing issue | Eisai is working to have product available again. For information on Patient Access Program, please visit: http://www.ontak.com/ |
Orphenadrine Citrate Injection (Initial Posting Date) - 1/23/2012
| Company/Products | Reason | Related Information | Updated |
|---|---|---|---|
| Akorn: 847-279-6100 30 mg/mL, 2 mL vial, 10 count (NDC 17478-0538-02) | Increased demand | Readily available. | Reverified 4/27/2012 |
| Bedford: Orphenadrine citrate injection 30 mg/mL Bedford | Bedford currently not producing. | ||
Sagent: 30 mg/mL, 2 mL vial, 10 count (NDC 25021-0651-02) | Available | Sagent has the 2mL presentation of orphenadrine citrate injection available. | Reverified 6/11/2012 |
Watson: 30 mg/mL, 2 mL vial, 10 count (NDC 00591-3222-47) | Available | Available | Reverified 5/17/2012 |
Oxsoralen (methoxsalen) 1% topical lotion (7/6/2010)
| Company/Products | Reason | Related Information |
|---|---|---|
| Valeant Pharmaceuticals International 1-866-819-9007 | Manufacturing delays | There is not yet an estimated release date. |
Oxymorphone Hydrochloride Oral Tablet (Initial Posting-3/19/2012)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Roxane Customer Service: 1-800-243-0127 5mg tablets, 100 count (NDC 00054-0283-25) 10mg tablets, 100 count (NDC 00054-0284-25) | Increase in market demand and API availability | RLI has accelerated production on this product and additional inventory of both the 5 mg and 10 mg is now available. | Revised 5/10/2012 |
Endo Pharmaceuticals Inc.
Opana (oxymorphone hydrochloride): 10mg tablet, 100 count bottle (NDC 63481-0613-70) 5mg tablet, 100 count bottle (NDC 63481-0612-70) Oxymorphone Hydrochloride: 10mg tablet, 100 count bottle (NDC 60951-0795-70) 5mg tablet, 100 count bottle (NDC 60951-0794-70) | Material shortage (API) | Temporarily unavailable and Endo cannot estimate a release date at this time. We will continue to provide updates as further information becomes available. | Reverified 5/15/2012 |
Oxytocin Injection, USP (synthetic)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 10 mL MDV (10 USP units/mL) (NDC 63323-012-10) | APP has all Oxytocin presentations available. | Check wholesaler for inventory. | Available | Reverified 5/25/2012 |
| 1 mL SDV (Plastic Vial) (10 USP units/mL) (NDC 63323-012-01) | |||||
| 30 mL MDV (10 USP units/mL) (NDC 63323-012-30) | |||||
| JHP Pharma 1-877-547-4547 | 1 mL vial (10 USP units/mL) (NDC 42023-116-25) | 1 mL SDV is currently on short-term back-order. Company has increased production with an estimated release date of April 25, 2012.
10 mL vial in 1 and 25s: Available in adequate stock. | Increase in demand | Revised 4/13/2012 | |
| 10 mL vial (10 USP units/mL) (NDC 42023-116-01) | |||||
| 10 mL vial (10 USP units/mL) (NDC 42023-116-02) | |||||
| West-Ward Pharmaceuticals Customer Service: 1-888-229-0001 | 1 mL vial (NDC 0641-6114-25) | Currently has limited quantities of the 1 mL vial available Expected lots available in June - July 2012 timeframe. | West-Ward has accelerated production and is expecting to have additional lots available for both 1 mL and 10 mL vial presentations in the June - July 2012 timeframe. Product will be made available as it is released.
| Increase in product demand | Revised 6/6/2012 |
| 10 mL vial (NDC 0641-6115-25) | 10 ml vial presentation is on backorder Expected lots available in June - July 2012 timeframe. |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Sandoz: | 30 mg/5 mL vial (NDC 66578-0043-01) | Currently on backorder | Manufacturing Delays | Revised 6/7/2012 | |
100 mg/16.7 mL vial (NDC 66578-0043-02) | |||||
300 mg/50 mL vial (NDC 66578-0043-03) | |||||
| APP 1-888-386-1300 | 30 mg/5 mL vial (NDC 63323-0763-05) | Available
| Please check wholesalers for inventory. | Increase in demand | Revised 6/15/2012 |
| 100 mg/16.7 mL vial (NDC 63323-0763-16) | Currently back-ordered. | ||||
| 300 mg/50 mL vial (NDC 63323-0763-50) | Available | ||||
| Hospira Inc. Customer Service: 1-877-946-7747 | 300 mg/50 mL vial (NDC 0409-0342-50) | Ample levels of inventory to support market demand. | Available | Reverified 6/8/2012 | |
30 mg/5 mL vial (NDC 0409-0342-09) | Ample levels of inventory to support market demand. | ||||
100 mg/16.7 mL vial (NDC 0409-0342-22) | Ample levels of inventory to support market demand. | ||||
| Bedford Laboratories 1-800-562-4797 | 30 mg/5 mL vial (NDC 55390-0114-05) | On backorder and the company cannot estimate a release date. | Manufacturing delays | ||
100 mg/16.7 mL vial (NDC 55390-0114-20) | |||||
300 mg/50 mL vial (NDC 55390-0114-50) | |||||
| Teva 1-800-545-8800 | 6mg/mL, 100 mg (NDC 00703-4766-01) | All presentations available with ample inventory. | Available | Reverified 6/4/2012 | |
6mg/mL, 30 mg (NDC 00703-4764-01) | |||||
6mg/mL, 150mg (NDC 00703-4767-01) | |||||
6mg/mL, 300mg (NDC 00703-4768-01) | |||||
| Sagent Pharmaceticals 1-866-625-1618 | 30 mg/5 mL (NDC 25021-213-05) | All 3 sizes available. | Reverified 6/11/2012 | ||
100 mg/16.7 mL | |||||
300 mg/50 mL | |||||
| Pfizer Customer Service: Pfizer Injectables 1-800-533-4535 | 30mg/5mL NDC (0069-0079-01) | Available | Available | Revised 4/16/2012 | |
100mg/16.7mL NDC (0069-0076-01) | Available | ||||
300mg/50mL NDC (0069-0078-01) | Available |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 1 mg/mL; 10 mL vial (NDC 0409-4646-01) | Next delivery August | Manufacturing delay | Revised 6/8/2012 |
Pegasys (peginterferon alfa-2a) Injection - Prefilled Syringes (Initial Posting-3/26/2012)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Genentech Genentech Resource Center: 180 mcg/mL Pegasys Prefilled syringe (PFS) for single use NDC 0004-0352-39 | Increased demand and Manufacturing delays of the Pre-filled Syringes | Potential limited availability of the PFS form of 180 mcg/mL Pegasys in the next 6 months (NDC 0004-0352-39, NDC 0004-0357-30). The firm anticipates that the potential shortage of the PFS will resolve by September 2012.
Please see the Dear Health Care Provider Letter (PDF - 147KB) and the Dear Pharmacist Letter (PDF - 147KB)
The firm has adequate supplies of the following presentations of Pegasys: * 180 mcg/0.5 mL Autoinjector for single use (NDC 0004-0365-09) *135 mcg/0.5 mL Autoinjector for single use (NDC 0004-0360-09) * 180 mcg/mL Vial for single use (NDC 0004-0350-09) |
Pentostatin for Injection (Nipent) (Initial Posting - 3/21/2012)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 10 mg vial (NDC 0409-0801-01 | Other manufacturer shortage/market withdrawal. | Product 10 mg vial (NDC 0409-0801-01 ): next delivery June. Please check with your wholesaler for available inventory. | Reverified 6/8/2012 |
| Bedford Customer Service 1-800-562-4797 10mg vial; ( NDC 55390-0244-01) | Manufacturing Delays | Bedford Laboratories has 10 mg lyophilized powder for injection available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford Laboratories website. | Revised 4/10/2012 |
Perflutren Lipid Microsphere (DEFINITY ) Injection
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
Lantheus Medical Imaging 4 vial kit (NDC 11994-011-04) | Manufacturing delay | Lantheus will have Definity on back order and at this time the company cannot estimate a release date. | 5/4/2012 |
Phentolamine Mesylate (updated 6/4/2012)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Bedford Customer Service: 1-800-562-4797 | Phentolamine mesylate for injection, 5 mg lyophilized vial (NDC 55390-0113-01) | On backorder | Bedford has phentolamine on backorder and the company cannot estimate a release date. | Manufacturing delay | Reverified 5/29/2012 |
| Sandoz Inc Customer Service: 800-525-8747 | Phentolamine Mesylate Injection 5mg/mL (boxes of 10-1 mL single dose vials) NDC 00781-3028-95 | Please contact your wholesaler or Sandoz Customer Service at 800-525-8747 for ordering information. | Sandoz in conjunction with FDA has initiated temporary importation of phentolamine mesylate injection into the US market to address this shortage. The Sandoz phentolamine mesylate injection 5 mg/mL product contains the same active ingredient, phentolamine mesylate, as the phentolamine mesylate for injection 5 mg vial product approved in the United States. However, there are important differences between the US product and Canadian product that Healthcare providers should be aware of before prescribing and product preparation. Please see the Dear Healthcare Professional Letter (PDF - 260KB) for additional product and supply information. | Revised 6/6/2012 |
Phytonadione Injectable Emulsion (Vitamin K)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1 mg/0.5 mL; 0.5 mL amp (NDC 0409-9157-01) | Next delivery June | Please check with your wholesaler for available inventory. | Manufacturing delay | Revised 6/8/2012 |
| 10 mg/mL; 1 mL amp | Next delivery June | ||||
| Amphastar Pharmaceuticals, Inc./IMS 1-800-423-4136 | Vitamin K injection, contains polysorbate 80 and propylene glycol 1 mg/0.5 mL, SAF-T-JET prefilled syringe (NDC 00548-1240-00) (*New NDC # 76329-1240-5) | Available | Please note that Vitamin K injection, contains polysorbate 80 and propylene glycol | Available | Revised 6/5/2012 |
Vitamin K injection, contains polysorbate 80 and propylene glycol 1 mg/0.5 mL, MINIJET prefilled syringe (NDC 00548-1140-00) (*New NDC# 76329-1140-5) | Available |
Pilocarpine HCL Opthalmic Gel 4% (Pilopine HS) (Initial posting-6/1/12)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Alcon Customer Service: 1-800-862-5266 | PILOPINE HS (pilocarpine hydrochloride ophthalmic gel) 4% 4 gm tube: (NDC 0065-0215-35) | Unable to estimate a release date | Updates will be provided as further information becomes available. | Manufacturing delay |
Potassium Chloride Injection 2 mEq/mL (Initial posting - 5/15/2012)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP Pharmaceuticals 1-888-386-1300 | 2 mEq/mL, 5 mL vials, (NDC 63323-0965-05) | APP is currently back-ordered on all presentations of potassium chloride and is releasing product intermittently. The firm anticipates next delivery of the 5 mL, 10 mL & 30 mL presentations late May 2012 | Increased demand | Reverified 5/25/2012 | |
| 2 mEq/mL, 10 mL vials, (NDC 63323-0965-10) | |||||
| 2 mEq/mL, 15 mL vials, (NDC 63323-0965-15) | |||||
| 2 mEq/mL, 20 mL vials, (NDC 63323-0965-20) | |||||
| 2 mEq/mL, 30 mL vials, (NDC 63323-0967-30) | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 2 mEq/mL; 250 mL bottle (NDC 0409-1513-02) | Next delivery August. | Please check with your wholesaler for available inventory. | Manufacturing delay; Higher than anticipated market demand for NDC 0409-6636-01. | Revised 6/8/2012 |
| Next delivery June | |||||
| 2 mEq/mL; 5 mL vial (NDC 0409-6635-01) | |||||
| 2 mEq/mL; 15 mL vial (NDC 0409-6636-01) | Next delivery July | ||||
| 2 mEq/mL; 10 mL vial (NDC 0409-6651-06) | Next delivery June | ||||
| 2 mEq/mL; 20 mL vial (NDC 0409-6653-05) | Next delivery June | ||||
| 10 mEq/100 mL (NDC 00409-7074-26) | Ample supplies available to meet market demand. | ||||
| 10 mEq/50 mL (NDC 00409-7075-14) | Ample supplies available to meet market demand. | ||||
| 20 mEq/100 mL, (NDC00409-7075-26) | Ample supplies available to meet market demand. | ||||
| 20 mEq/50 mL (NDC 00409-7077-14) | Ample supplies available to meet market demand. | ||||
| 40 mEq/100 mL (NDC 00409-7077-26) | Ample supplies available to meet market demand. | ||||
| 40 mEq/1000 mL (NDC 00409-7116-09) | Ample supplies available to meet market demand. | ||||
| 20 mEq/1000 mL in 0.9% NaCl (NDC 00409-7115-09) | Ample supplies available to meet market demand. | ||||
| 20 mEq/1000 mL in 5% dextrose (NDC 00409-7905-09) | Ample supplies available to meet market demand. | ||||
| 10 mEq/500 mL in 5% dex & 0.225% NaCl (NDC 00409-7901-03) | Ample supplies available to meet market demand | ||||
| 10 mEq/ 500 mL in 5% dex 0.45% NaCl (NDC 00409-7902-03) | Ample supplies available to meet market demand. | ||||
| 20 mEq/1000 mL in 5% dex& 0.225% NaCl (NDC 00409-7901-09) | Ample supplies available to meet market demand. | ||||
| 20 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 00409-7902-09) | Ample supplies available to meet market demand. | ||||
| 30 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 00409-7903-09) | Ample supplies available to meet market demand. | ||||
| 40 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 00409-7904-09) | Ample supplies available to meet market demand | ||||
| 10 mEq/1000 mL in 5% dex & 0.45% NaCl (NDC 00409-7993-09)20 mEq/1000 mL in 5% dex & 0.9% NaCl (NDC 00409-7107-09) | Ample supplies available to meet market demand | ||||
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Hospira Inc. | 3 mMol/mL, 15 mL vial (NDC 0409-7295-01) | Next delivery June |
| Available | Revised 6/8/2012 |
| American Regent/Luitpold 1-800-645-1706 | 3 mMol/mL, 5 mL vial (NDC 00517-2305-25) | Unavailable | American Regent//Luitpold is not manufacturing the 5 mL vials and 15 mL vials.
Please check with your wholesaler for available inventory. | Revised 6/8/2012 | |
| 3 mMol/mL, 15 mL vial (NDC 00517-2315-25) | Unavailable | ||||
| 3 mMol/mL, 50 mL vial (NDC 00517-2350-25) | Available |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 100 mg/mL; 10 mL vial (NDC 0409-1902-01) | Ample levels of inventory to support market demand. | Please check with your wholesaler for available inventory.
| Manufacturing delays | Revised 6/8/2012 |
500 mg/mL; 2 mL vial (NDC 0409-1903-01) | Next delivery September |
Prochlorperazine Injection (1/30/2012)
| Company/Products | Reason | Related Information |
|---|---|---|
| Bedford Customer Service 1-800-562-4797 5 mg/mL 2 mL vial, 10 count (NDC 55390-0077-10) 10 mL vial (NDC 55390-0077-01) | Manufacturing delays | Bedford has both prochlorperazine 5 mg/mL injection presentations on back order and the company cannot estimate a release date. The 2 mL vials are pending release while the 10 mL vials will not be manufactured until capacity permits.
|
Promethazine Injection (Initial Posting Date) - 2/10/2012
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 25 mg/mL 1 mL | Manufacturing delay | Hospira has Promethazine 25 mg/mL 1 mL Carpuject syringes on back order and the company estimates a release date in 2013. | Reverified 6/8/2012 |
| Teva Phamaceuticals 1-800-545-8800 25 mg/mL; 1 mL vial (NDC 00703-2191-04) 50 mg/mL; 1 mL vial (NDC 00703-2201-04 | Manufacturing delay | Teva has all promethazine injection presentations on back order and the company cannot estimate a release date. | Reverified 6/4/2012 |
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 (Formerly a Baxter Product) Promethazine Phenergan | Increase in product demand. | West-Ward is currently experiencing a backorder situation on Promethazine 25 mg/mL,1 mL vial, 50 mg/mL, 1 mL ampul and Phenergan 25 mg/mL, 1 mL vial. All other codes are available in limited quantities.
West-Ward has accelerated production and will have units of all presentations available for release in the March – April 2012 timeframe.
Product will be made available as it is released | Revised 4/24/2012 |
Propofol Injection (Initial Posting Date) - 4/5/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 20 mL (NDC 63323-270-20) | APP is releasing Propofol directly into the channel. | Please check wholesalers for available inventory. | Increased demand | Revised 5/29/2012 |
| 50 mL (NDC 63323-270-50) | |||||
| 100 mL (NDC 63323-270-65) | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 10 mg/mL; 20 mL (NDC 0409-4699-30) | Next delivery August | Please check with your wholesaler for available inventory. | Manufacturing delay | Revised 6/8/2012 |
| 10 mg/mL; 50 mL (NDC 0409-4699-33) | Next delivery TBD | ||||
| 10 mg/mL; 100 mL (NDC 0409-4699-24) | Next delivery August | ||||
Protonix (pantoprazole) Injection (Initial Posting Date) - 2/23/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Pfizer
Pfizer Injectables | 40 mg vial, package of 10 (NDC 00008-0923-55) | Pfizer has resumed shipping on March 14th. | Manufacturing delays | Revised 5/22/2012 | |
| 40 mg vial, package of 25 (NDC 00008-0923-60) | On backorder until September 2012. | ||||
| 40 mg Novaplus vial, package of 10 (NDC 00008-0941-04) | Pfizer has resumed shipping on March 14th. |
Secretin Injection (ChiRhoStim)(Initial posting-6/15/12)
| Company | Products | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| ChiRhoClin Customer service- 1-877-272-4888 | 16 mcg vial (NDC 67066-2225-01) | No presentations are available. | On back order and the company cannot estimate a release date. | Cannot provide a reason for the shortage. |
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| American Regent/Luitpold 1-800-645-1706 40 mcg/mL, 10 mL vial (NDC 00517-6610-25) | Manufacturing delays | American Regent has Selenium Injection on back order and the company cannot estimate a release date. | Reverified 3/19/2012 |
Sodium Acetate Injection (Initial Posting Date) - 1/31/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 2 mEq/mL, 100 mL vial (NDC 63323-0032-61) | APP has sodium acetate on back order and expects a release mid-June. | Increased Demand | Reverified 5/25/2012 | |
American Regent, Inc./Luitpold | 2 mEq/mL, 20 mL vial (NDC 00517-2096-25) | Currently not releasing. | Unavailable | Revised 6/8/2012 | |
| 2 mEq/mL, 100 mL vial (NDC 00517-2500-25) | Discontinued. | ||||
| 4 mEq/mL, 50 mL vial (NDC 00517-5023-25) | Currently not releasing | ||||
| Hospira Inc. Customer Service 1-877-946-7747 | 2 mEq/mL; 20 mL vial (NDC 0409-7299-73) | Next delivery June | Please check with your wholesaler for available inventory. | Other manufacturer shortage/market withdrawal. | Revised 6/8/2012 |
| 2 mEq/mL; 50 mL vial (NDC 0409-3299-05) | Next delivery June | ||||
| 2 mEq/mL; 100 mL vial (NDC 0409-3299-06) | Next delivery June |
Sodium Bicarbonate Injection (Initial Posting-3/20/12)
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Amphastar Pharmaceuticals Inc. Customer Service: 1-800-423-4136 | Sodium Bicarbonate Injection USP, 8.4%, 50 mL Prefilled Syringe NDC: 0548-3352-00) (*New NDC# 76329-3352-1) | Will regularly release products. | Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues. | Increase demand | Revised 6/5/2012 |
APP | 4.2% 2.5 mEq, 5 mL (NDC 63323-0026-05) | APP is currently back-ordered and expects a release late May. | Please check wholesalers for inventory. | Increased demand | Reverified 5/25/2012 |
| Hospira, Inc. Customer Service: 1-877-946-7747 | 4%; 5 mL vial (NDC 0409-6609-02) | Next delivery June | Please check with your wholesaler for available inventory. | Manufacturing delay; Other manufacturer shortages/market withdrawal. | Revised 6/8/2012 |
| 0.5 mEq/mL; 10 mL Abboject (NDC 0409-5534-34) | Ample levels of inventory to support market demand | ||||
| 0.9 mEq/mL; 50 mL Abboject (NDC 0409-4916-34) | Next delivery TBD | ||||
| 1 mEq/mL; 50 mL vial (NDC 0409-6625-02) | Next delivery June | ||||
| 1 mEq/mL; 50 mL Abboject (NDC 0409-6637-34) | Next delivery TBD | ||||
| 1 mEq/mL; 10 mL Abboject (NDC 0409-4900-34) | Ample levels of inventory to support market demand |
Sodium Chloride 0.9% (5.8mL and 20mL) (Initial Posting Date) – 5/4/2012
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Lantheus Medical Imaging 1-800-299-3431 Sodium Chloride 0.9% (5.8mL and 20mL) Supplied in packs of 6 vials (5.8mL NDC # 11994-512-05 and 20mL NDC # 11994-512-20) with Technetium Tc99m Generator | Manufacturing delays at contract manufacturer. | Commercially available Sodium Chloride has inconsistent inventory availability. Lantheus has Sodium Chloride 0.9% (5.8mL and 20mL) on back order and cannot estimate a release date. |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 30 mL vials (NDC 63323-0087-30) | APP has sodium chloride 23.4% solution for injection on intermittent back order and the company is releasing product as it becomes available. | Increased demand | Reverified 5/25/2012 | |
| 100 mL vials (NDC 63323-0088-61) | |||||
| 200 mL vials (NDC 63323-0088-63) | |||||
| American Regent/Luitpold 1-800-645-1706 | 30 mL vials (NDC 00517-2930-25) | Unavailable | American Regent/Luitpold is no longer manufacturing Sodium Chloride Injection 23.4%.. | Revised 6/8/2012 | |
| 100 mL vials (NDC 00517-2900-25) | |||||
| Hospira Inc. Customer Service: 1-877-946-7747 | 4 mEq/mL; 250 mL bottle (NDC 0409-1130-02) | Expected availability is TBD. |
| Manufacturing delay | Reverified 6/8/2012 |
| 4 mEq/mL; 100 mL bottle (NDC 0409-1141-02) | Expected availability is TBD. |
Sodium Lactate Injection (Initial Posting Date – 5/17/2012)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Hospira, Inc. Customer Service 1-877-946-7747 5 mEq/mL; 10 mL, 25s(NDC 00409-6664-02) | Manufacturing delay | Product 5 mEq/mL; 10 mL vial (NDC 0409-6664-02): next delivery July. Please check with your wholesaler for available inventory. | Reverified 6/8/2012 |
| Baxter Customer Service 1-800-262-3784 167 mEq/mL; 1000 mL (NDC 00338-0129-04) | Product has been discontinued | Baxter has discontinued manufacturing of the product. | 5/17/2012 |
Sodium Nitrite Injection (Initial posting-5/29/12)
| Company | Products | Availability information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hope Pharmaceuticals Customer Service: 1-800-755-9595 | 300mg/10ml; (30mg/ml) (NDC# 60267-311-10) | Available |
| 5/29/2012 |
Sodium Nitrite; Sodium Thiosulfate Injection (Initial posting-5/29/12)
| Company | Products | Availability information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Hope Pharmaceuticals Customer Service: 1-800-755-9595 | SODIUM NITRITE; SODIUM THIOSULFATE 300MG/10ML(30MG/ML),N/A;N/A,12.5GM/50ML(250MG/ML (NDC 60267-812-00) | Available |
| 5/29/2012 | |
| Akorn Pharmaceuticals 1-800-932-5676 | SODIUM NITRITE; SODIUM THIOSULFATE (NDC# 11098-0507-01) | Discontinued | 5/29/2012 |
Sodium Thiosulfate Injection (Initial posting-5/29/12)
| Company | Products | Availability information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Hope Pharmaceuticals Customer Service: 1-800-755-9595 | SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) (NDC # 60267-705-50) | Available |
| 5/29/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Akorn: 847-279-6100 | Sufenta 50 mcg/mL 1 mL ampule (NDC 17478-0050-01) | 1 mL ampoule (NDC 17478-0050-01) Readily available 2 mL ampoule (NDC 17478-0050-02) Due to release in June 5 mL ampoule (NDC 17478-0050-05) Readily available. |
| Material Shortage | 4/27/2012 |
Sufenta 50 mcg/mL 2 mL ampule (NDC 17478-0050-02) | |||||
Hospira, Inc. | Sufentanil 50 mcg/mL
| Next delivery September | Please check with your wholesaler for all available inventory. | Manufacturing delay | Reverified 6/8/2012 |
Sufentanil 50 mcg/mL 1 mL vial (NDC 0409-3382-21) | Next delivery September | ||||
Sufentanil 50 mcg/mL 2 mL ampule (NDC 0409-3380-32) | Next delivery September | ||||
Sufentanil 50 mcg/mL 2 mL Novaplus ampule (NDC 0409-3380-50) | |||||
Sufentanil 50 mcg/mL 2 mL vial (NDC 0409-3382-22) | Next delivery September | ||||
Sufentanil 50 mcg/mL 5 mL ampule (NDC 0409-3380-35) | Next delivery September | ||||
| Sufentanil 50 mcg/mL 5 mL vial (NDC 0409-3382-25) | |||||
| West-Ward (formerly Baxter products) Customer Service: 1-888-229-0001 | 1 mL ampul (NDC 0641-6110-10) | Multiple lots of each code are scheduled for production and anticipated to be available in the June - July 2012 timeframe. | Backorder.
Product will be made available as it is released. | Increase in product demand due to market supply issues | Revised 5/31/2012 |
2 mL ampul (NDC 0641-6111-10) | |||||
5 mL ampul (NDC 0641-6112-10) |
Sulfamethoxazole 80mg/trimethoprim 16mg/ml injection (SMX/TMP)
| Company | Products | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Teva Pharmaceuticals | 80 mg/16 mg/mL, 5 mL (NDC 00703-9503-03) | Teva is reviewing orders for the 5mL and 10mL presentations prior to distribution. | Manufacturing Delays | Revised 6/4/2012 | |
| 80 mg/16 mg/mL, 10 mL (NDC 00703-9514-03) | |||||
| 80 mg/16 mg/mL, 30 mL (NDC 00703-9526-01 | The 30 mL is on back order and Teva estimates a release date of Jan 2013. | ||||
Telavancin (Vibativ) Injection (updated 1/6/2012)
| Company/Products | Reason | Related Information |
|---|---|---|
| Astellas Pharma US, Inc. 1-800-727-7003 NDC 00469-3575-50 NDC 00469-3525-30 | Manufacturing delays | Astellas has no estimated date of availability.
|
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Teva Pharmaceuticals 1-800-545-8800 | 250 mg, 100 count (NDC 00172-2416-60) | Temporarily unavailable | Teva has all tetracycline capsules temporarily unavailable and the company cannot estimate a release date. | Reverified 5/18/2012 | |
| 250 mg, 100 count unit dose (NDC 00172-2416-10) | Temporarily unavailable | ||||
| 250 mg, 1000 count (NDC 00172-2416-80) | Temporarily unavailable | ||||
| 500 mg, 100 count (NDC 00172-2407-60) | Temporarily unavailable | ||||
| 500 mg, 100 count unit dose (00172-2407-10) | Temporarily unavailable | ||||
| 500 mg, 1000 count (NDC 00172-2407-80) | Temporarily unavailable | ||||
| Watson Customer Service: (973) 355-8300 | 250 mg, 100 count (NDC 00591-2234-01) | Watson has all tetracycline capsules temporarily unavailable and the company cannot estimate a release date. | Manufacturing delays | Reverified 5/17/2012 | |
| 250 mg, 1000 count (NDC 00591-2234-10) | |||||
| 500 mg, 100 count (NDC 00591-2235-01) | |||||
| 500 mg, 1000 count (NDC 00591-2235-10) |
Thiotepa for Injection (updated 12/2/2011)
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Bedford Laboratories Customer Service 1-800-562-4797 15 mg/mL vial (NDC 55390-0030-10) | Manufacturing delays | Bedford Laboratories has 15mg available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford Laboratories website. | Revised 4/10/2012 |
| Adienne | Adienne, in conjunction with the FDA, is initiating a temporary importation of Thiotepa for injection, to the United States market. Please see the Dear Healthcare Professional Letter (PDF - 87KB) for information about emergency supplies that are now available to help address the shortage. | Revised 5/15/2012 |
Thyrogen (thyrotropin alfa) injection 1.1mg/vial (updated 11/22/2011)
| Company/Products | Reason | Related Information |
|---|---|---|
| Genzyme Corporation 1-800-745-4447 | Temporary Delays | Intermittent shipments of the product have resumed globally. Genzyme continues to expect that Thyrogen supply constraints will occur through 2012. |
Thyrolar Tablets (12/31/2009)
| Company/Products | Reason | Related Information |
|---|---|---|
| Forest Pharmaceuticals | Manufacturing delays | Forest has not yet reported when Thyrolar will be available. |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Teva Pharmaceuticals 1-800-545-8800 | 250 mg, 100 count (NDC 00093-0154-01) | Teva has ticlopidine tablets in stock | N/A | Reverified 5/18/2012 | |
| Apotex Corporation Customer Service: 1-(877)-4-Apotex | 250 mg, 30 count (NDC 60505-0027-02) | Apotex has Ticlopidine Tablets on back order and the company estimates a tentative release date of June, 2012. | Manufacturing delays | Revised 5/11/2012 | |
| 250 mg, 60 count (NDC 60505-0027-04) | |||||
| 250 mg, 500 count (NDC 60505-0027-07) | |||||
| 250 mg, 500 count (NDC 60505-0027-07) |
Tobramycin Solution for Injection
| Company | Products | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Teva Pharmaceuticals | 40 mg/mL, 2 mL vial (NDC 00703-9402-04) | All tobramycin 40 mg/mL solution for injection on long term back order and the company cannot estimate a release date. | Manufacturing delays | Reverified 6/4/2012 | |
| 40 mg/mL, 30 mL vial (NDC 00703-9416-01) | |||||
Pfizer Pfizer Injectables
| 40 mg/mL, 2 mL vial (NDC 00069-0088-02) | The 2mL vial is expected to be available in mid August. | Manufacturing delays | Revised 5/22/2012 | |
| 40 mg/mL, 30 mL vial (NDC 00069-0091-03) | Available | ||||
APP
| 10 mg/ml; 2ml vial (NDC 63323-0305-02) | Available | Check wholesalers for inventory. | Increase in demand/manufacturing delays
| Reverified 5/25/2012 |
| 40 mg/mL, 2 mL vial (NDC 63323-0306-02) | |||||
| 40 mg/mL, 30 mL vial (NDC 63323-0306-30) | |||||
| 40 mg/mL, 50 mL vial (NDC 63323-0307-51) | |||||
| 40 mg/mL, 2 mL Novaplus vial (NDC 63323-0306-55) | |||||
| 40 mg/mL, 30 mL Novaplus vial (NDC 63323-0306-56) | |||||
| Tobramycin Lyophilized Powder for Injection 1.2 gram 50 mL vial, preservative-free, 6 count (NDC 63323-0303-51) | |||||
| 1.2 gram 50 mL Novaplus vial, preservative-free, 6 count (NDC 63323-0303-55) | |||||
| Hospira, Inc. Customer Service 1-877-946-7747 | 10 mg/mL; 2 mL vial (NDC 0409-3577-01) | Next delivery June 2012 | Please check with your wholesaler for available inventory. | Other manufacturer shortage/market withdrawal. | Reverified 6/8/2012 |
| 40 mg/mL; 2 mL vial (NDC 0409-3578-01) | Next delivery June 2012 | ||||
| 40 mg/mL; 50 mL vial (NDC 0409-3590-02) | Next delivery June 2012 | ||||
Tromethamine Injection (Initial Posting Date) - 5/2/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 0.3 M; 500 mL bottle (NDC 0409-1593-04) | Next delivery July | Please check with your wholesaler for available inventory. | Manufacturing delay | Revised 6/8/2012 |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| American Regent/Luitpold 1-800-645-1706 | 20 units/mL; 0.5 mL multi-dose vial, 25 count (NDC 00517-0510-25) | Available | Please check with your wholesaler for available inventory. | Revised 6/8/2012 | |
| 20 units/ml; 1 mL multi-dose vial, 25 count (NDC 00517-1020-25) | |||||
| 20 units/ml; 10 mL multi-dose vial, 25 count (NDC 00517-0410-10) |
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
Bedford Laboratories | 10 mg (NDC 55390-0037-10) | Bedford Laboratories has 10 mg and 20mg available in limited quantities. | Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford Laboratories website. | Manufacturing Delays | Revised 4/10/2012 |
| 20 mg (NDC 55390-0039-10) | |||||
| Sun Pharmaceutical Industries, Inc. 1-800-818-4555 | Sun Pharmaceutical Industries (Distributor: Caraco Pharmaceutical Labs, Ltd.) is continuing to release product as it becomes available. Vecuronium Bromide for Injection 10 mg 10 vials NDC 41616-0931-44 Vecuronium Bromide for Injection 20 mg 10 vials NDC 41616-0932-44 | Increase in demand | |||
Teva Pharmaceuticals
| 10 mg vials, package of 10 (NDC 00703-2914-03) | On long term backorder | The company cannot estimate a release date. | Manufacturing delay | Reverified 6/4/2012 |
| 20 mg vials, package of 10 (NDC 00703-2925-03) | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747
| 10 mg vial (NDC 0409-1632-01) | Temporarily suspended | Manufacturing delay | Reverified 6/8/2012 | |
| 20 mg vial (NDC 0409-1634-01) | Next delivery May | ||||
| Sagent Pharmaceticals 1-866-625-1618
| 10mg/vial NDC 25021-657-10 | Both products are available | Reverified 6/11/2012 | ||
| 20mg/vial NDC 25021-658-20 | |||||
| Pfizer Customer Service: Pfizer Injectables 1-800-533-4535 | 10mg (0069-0094-02) | Pfizer Injectables has the following presentations of Vecuronium available: Vecuronium Injection 10mg (0069-0094-02) Vecuronium Injection 20mg (0069-0108-05) | Available | Reverified 5/21/2012 | |
| 20mg (0069-0108-05) |
Viaspan Cold Storage Solution 1000 mL Bag (Initial Posting Date) - 4/16/12
| Company/Products | Reason | Related Information | Date Updated |
|---|---|---|---|
| Distributed Under the Barr/Duramed Pharmaceuticals Label. Barr & Duramed are Affiliates of Teva Pharmaceuticals USA Teva Pharmaceutical | Product Recall of two (2) batches | ViaSpan is currently unavailable and will continue to be unavailable until early to mid June at the earliest. Comments: Contact information for this issue: |
Vinblastine Sulfate Injection (Initial Posting Date) - 1/31/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 1 mg/mL; 10 mL vial (NDC 63323-0278-10) | Available | Check wholesalers for inventory. | Increased Demand | Revised 5/29/2012 |
Zinc Injection (Initial Posting Date)- 2/15/2012
| Company | Product | Availability Information | Notes | Reason | Date Updated |
|---|---|---|---|---|---|
| American Regent/Luitpold 1-800-645-1706 | 1 mg/mL, 10 mL vial (NDC 00517-6110-25) | Unavailable | American Regent is currently not releasing the 10 mL vial.
Please check with your wholesaler for available inventory. | Revised 6/8/2012 | |
| 5 mg/mL, 5 mL vial (NDC 00517-8105-25) | |||||
| Available | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1 mg/mL, 10 mL vial (NDC 0409-4090-01) | Next delivery July | Please check with your wholesaler for all available inventory. | Manufacturing delay | Revised 6/8/2012 |
-
Read more http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm#fospropofol